organization · Reporting owner
Hellman & Friedman Investors VIII, L.P.
Disclosed activity across 3 companies
Sign in to followReported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Claritev CorpCTEV · Entity 5238 | 10% owner | November 12, 2025 | November 14, 2025 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Claritev Corp
Report date November 12, 2025 · Filed November 14, 2025
Jointly reported with H&F Corporate Investors VIII, Ltd., Hellman & Friedman Capital Partners VIII, L.P., Hellman & Friedman Capital Partners VIII (Parallel), L.P., HFCP VIII (Parallel - A), L.P., H&F Executives VIII, L.P., H&F Associates VIII, L.P., H&F Polaris Partners, L.P., H&F Polaris Partners GP, LLC
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | IndirectSee Footnotes | 2,024,899 |
Reported balance
After 2025-11-12 transaction · row 1
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 1 · 2025-11-12 · Sale · Disposed 789,936 · Balance 2,024,899 F1: The shares of Class A common stock were sold in connection with an underwritten public offering of the Issuer. The shares were sold at a price per share equal to the public offering price, net of underwriting discounts and commissions. F2: Represents shares sold directly by Hellman & Friedman Capital Partners VIII, L.P. ("HFCP VIII"). F8: Hellman & Friedman Investors VIII, L.P. ("H&F Investors VIII") is the general partner of each of the H&F VIII Funds. H&F Corporate Investors VIII, Ltd. ("H&F VIII") is the general partner of H&F Investors VIII. A three member board of directors of H&F VIII has investment discretion over the shares held by the H&F VIII Funds and Polaris Partners. The Reporting Persons states that this filing shall not be an admission that the Reporting Persons are the beneficial owners of any of the securities reported herein, and each Reporting Person disclaims beneficial ownership of such securities except to the extent of such Reporting Person's pecuniary interest therein. |
| Class A Common StockSEC Table I · non-derivative | IndirectSee Footnotes | 908,778 |
Reported balance
After 2025-11-12 transaction · row 2
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 2 · 2025-11-12 · Sale · Disposed 354,524 · Balance 908,778 F1: The shares of Class A common stock were sold in connection with an underwritten public offering of the Issuer. The shares were sold at a price per share equal to the public offering price, net of underwriting discounts and commissions. F3: Represents shares sold directly by Hellman & Friedman Capital Partners VIII (Parallel), L.P. ("HFCP VIII Parallel"). F8: Hellman & Friedman Investors VIII, L.P. ("H&F Investors VIII") is the general partner of each of the H&F VIII Funds. H&F Corporate Investors VIII, Ltd. ("H&F VIII") is the general partner of H&F Investors VIII. A three member board of directors of H&F VIII has investment discretion over the shares held by the H&F VIII Funds and Polaris Partners. The Reporting Persons states that this filing shall not be an admission that the Reporting Persons are the beneficial owners of any of the securities reported herein, and each Reporting Person disclaims beneficial ownership of such securities except to the extent of such Reporting Person's pecuniary interest therein. |
| Class A Common StockSEC Table I · non-derivative | IndirectSee Footnotes | 171,740 |
Reported balance
After 2025-11-12 transaction · row 3
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 3 · 2025-11-12 · Sale · Disposed 66,997 · Balance 171,740 F1: The shares of Class A common stock were sold in connection with an underwritten public offering of the Issuer. The shares were sold at a price per share equal to the public offering price, net of underwriting discounts and commissions. F4: Represents shares sold directly by HFCP VIII Parallel-A ("HFCP VIII Parallel-A"). F8: Hellman & Friedman Investors VIII, L.P. ("H&F Investors VIII") is the general partner of each of the H&F VIII Funds. H&F Corporate Investors VIII, Ltd. ("H&F VIII") is the general partner of H&F Investors VIII. A three member board of directors of H&F VIII has investment discretion over the shares held by the H&F VIII Funds and Polaris Partners. The Reporting Persons states that this filing shall not be an admission that the Reporting Persons are the beneficial owners of any of the securities reported herein, and each Reporting Person disclaims beneficial ownership of such securities except to the extent of such Reporting Person's pecuniary interest therein. |
| Class A Common StockSEC Table I · non-derivative | IndirectSee Footnotes | 53,118 |
Reported balance
After 2025-11-12 transaction · row 4
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 4 · 2025-11-12 · Sale · Disposed 20,722 · Balance 53,118 F1: The shares of Class A common stock were sold in connection with an underwritten public offering of the Issuer. The shares were sold at a price per share equal to the public offering price, net of underwriting discounts and commissions. F5: Represents shares sold directly by H&F Executives VIII, L.P. ("H&F VIII Executives"). F8: Hellman & Friedman Investors VIII, L.P. ("H&F Investors VIII") is the general partner of each of the H&F VIII Funds. H&F Corporate Investors VIII, Ltd. ("H&F VIII") is the general partner of H&F Investors VIII. A three member board of directors of H&F VIII has investment discretion over the shares held by the H&F VIII Funds and Polaris Partners. The Reporting Persons states that this filing shall not be an admission that the Reporting Persons are the beneficial owners of any of the securities reported herein, and each Reporting Person disclaims beneficial ownership of such securities except to the extent of such Reporting Person's pecuniary interest therein. |
| Class A Common StockSEC Table I · non-derivative | IndirectSee Footnotes | 8,932 |
Reported balance
After 2025-11-12 transaction · row 5
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 5 · 2025-11-12 · Sale · Disposed 3,485 · Balance 8,932 F1: The shares of Class A common stock were sold in connection with an underwritten public offering of the Issuer. The shares were sold at a price per share equal to the public offering price, net of underwriting discounts and commissions. F6: Represents shares sold directly by H&F Associates VIII, L.P. ("H&F VIII Associates", and together with HFCP VIII, HFCP VIII Parallel, HFCP VIII Parallel-A and H&F VIII Executives, the "H&F VIII Funds"). F8: Hellman & Friedman Investors VIII, L.P. ("H&F Investors VIII") is the general partner of each of the H&F VIII Funds. H&F Corporate Investors VIII, Ltd. ("H&F VIII") is the general partner of H&F Investors VIII. A three member board of directors of H&F VIII has investment discretion over the shares held by the H&F VIII Funds and Polaris Partners. The Reporting Persons states that this filing shall not be an admission that the Reporting Persons are the beneficial owners of any of the securities reported herein, and each Reporting Person disclaims beneficial ownership of such securities except to the extent of such Reporting Person's pecuniary interest therein. |
| Class A Common StockSEC Table I · non-derivative | IndirectSee Footnotes | 677,590 |
Reported balance
After 2025-11-12 transaction · row 6
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 6 · 2025-11-12 · Sale · Disposed 264,336 · Balance 677,590 F1: The shares of Class A common stock were sold in connection with an underwritten public offering of the Issuer. The shares were sold at a price per share equal to the public offering price, net of underwriting discounts and commissions. F7: Represents shares sold directly by H&F Polaris Partners, L.P. ("Polaris Partners"), the general partner of which is H&F Polaris Partners GP, LLC, the managing member of which is HFCP VIII. F8: Hellman & Friedman Investors VIII, L.P. ("H&F Investors VIII") is the general partner of each of the H&F VIII Funds. H&F Corporate Investors VIII, Ltd. ("H&F VIII") is the general partner of H&F Investors VIII. A three member board of directors of H&F VIII has investment discretion over the shares held by the H&F VIII Funds and Polaris Partners. The Reporting Persons states that this filing shall not be an admission that the Reporting Persons are the beneficial owners of any of the securities reported herein, and each Reporting Person disclaims beneficial ownership of such securities except to the extent of such Reporting Person's pecuniary interest therein. |
Filing footnotes · ownership attribution and instrument terms
F1: The shares of Class A common stock were sold in connection with an underwritten public offering of the Issuer. The shares were sold at a price per share equal to the public offering price, net of underwriting discounts and commissions.
F2: Represents shares sold directly by Hellman & Friedman Capital Partners VIII, L.P. ("HFCP VIII").
F3: Represents shares sold directly by Hellman & Friedman Capital Partners VIII (Parallel), L.P. ("HFCP VIII Parallel").
F4: Represents shares sold directly by HFCP VIII Parallel-A ("HFCP VIII Parallel-A").
F5: Represents shares sold directly by H&F Executives VIII, L.P. ("H&F VIII Executives").
F6: Represents shares sold directly by H&F Associates VIII, L.P. ("H&F VIII Associates", and together with HFCP VIII, HFCP VIII Parallel, HFCP VIII Parallel-A and H&F VIII Executives, the "H&F VIII Funds").
F7: Represents shares sold directly by H&F Polaris Partners, L.P. ("Polaris Partners"), the general partner of which is H&F Polaris Partners GP, LLC, the managing member of which is HFCP VIII.
F8: Hellman & Friedman Investors VIII, L.P. ("H&F Investors VIII") is the general partner of each of the H&F VIII Funds. H&F Corporate Investors VIII, Ltd. ("H&F VIII") is the general partner of H&F Investors VIII. A three member board of directors of H&F VIII has investment discretion over the shares held by the H&F VIII Funds and Polaris Partners. The Reporting Persons states that this filing shall not be an admission that the Reporting Persons are the beneficial owners of any of the securities reported herein, and each Reporting Person disclaims beneficial ownership of such securities except to the extent of such Reporting Person's pecuniary interest therein.
Past disclosures · reporting ended (2)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
PPD, Inc.
Report date December 08, 2021 · Filed December 08, 2021
Jointly reported with H&F Corporate Investors VIII, Ltd., Hellman & Friedman Capital Partners VIII, L.P., Hellman & Friedman Capital Partners VIII (Parallel), L.P., HFCP VIII (Parallel - A), L.P., H&F Executives VIII, L.P., H&F Associates VIII, L.P.
Section 16 reporting ended · disclosed 2021-12-08. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | IndirectSee Footnotes | 0 |
Reported balance
After 2021-12-08 transaction · row 1
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 1 · 2021-12-08 · Sale · Disposed 52,884,036 · Balance 0 F1: On December 8, 2021, Thermo Fisher Scientific Inc., a Delaware corporation ("Buyer"), acquired the Issuer pursuant to a certain Agreement and Plan of Merger entered into by and among the Issuer, Buyer and Powder Acquisition Corp., a Delaware corporation and wholly-owned subsidiary of Buyer ("Merger Sub"), dated as of April 15, 2021 (the "Merger Agreement"). In accordance with the Merger Agreement, the Issuer merged with and into Merger Sub, with the Issuer surviving such merger as a wholly-owned subsidiary of Buyer (the "Merger"). At the effective time of the Merger, each issued and outstanding share of the Issuer's common stock (other than certain excluded shares) automatically converted into the right to receive $47.50 in cash. F2: Reflects securities directly held by Hellman & Friedman Capital Partners VII, L.P. ("HFCP VII"). F11: Hellman & Friedman Investors VII, L.P. ("H&F Investors VII") is the general partner of each of the H&F VII Funds. H&F Corporate Investors VII, Ltd. ("H&F VII") is the general partner of H&F Investors VII. Hellman & Friedman Investors VIII, L.P. ("H&F Investors VIII") is the general partner of each of the H&F VIII Funds. H&F Corporate Investors VIII, Ltd. ("H&F VIII") is the general partner of H&F Investors VIII. A three member board of directors of each of H&F VII and H&F VIII has investment discretion over the shares held by the H&F VII Funds and the H&F VIII Funds, respectively. Allen R. Thorpe, a member of the board of directors of PPD, Inc. is a member of the boards of directors of H&F VII and H&F VIII. |
| Common StockSEC Table I · non-derivative | IndirectSee Footnotes | 0 |
Reported balance
After 2021-12-08 transaction · row 2
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 2 · 2021-12-08 · Sale · Disposed 20,244,387 · Balance 0 F1: On December 8, 2021, Thermo Fisher Scientific Inc., a Delaware corporation ("Buyer"), acquired the Issuer pursuant to a certain Agreement and Plan of Merger entered into by and among the Issuer, Buyer and Powder Acquisition Corp., a Delaware corporation and wholly-owned subsidiary of Buyer ("Merger Sub"), dated as of April 15, 2021 (the "Merger Agreement"). In accordance with the Merger Agreement, the Issuer merged with and into Merger Sub, with the Issuer surviving such merger as a wholly-owned subsidiary of Buyer (the "Merger"). At the effective time of the Merger, each issued and outstanding share of the Issuer's common stock (other than certain excluded shares) automatically converted into the right to receive $47.50 in cash. F3: Reflects securities directly held by Hellman & Friedman Capital Partners VII (Parallel), L.P. ("HFCP VII Parallel"). F11: Hellman & Friedman Investors VII, L.P. ("H&F Investors VII") is the general partner of each of the H&F VII Funds. H&F Corporate Investors VII, Ltd. ("H&F VII") is the general partner of H&F Investors VII. Hellman & Friedman Investors VIII, L.P. ("H&F Investors VIII") is the general partner of each of the H&F VIII Funds. H&F Corporate Investors VIII, Ltd. ("H&F VIII") is the general partner of H&F Investors VIII. A three member board of directors of each of H&F VII and H&F VIII has investment discretion over the shares held by the H&F VII Funds and the H&F VIII Funds, respectively. Allen R. Thorpe, a member of the board of directors of PPD, Inc. is a member of the boards of directors of H&F VII and H&F VIII. |
| Common StockSEC Table I · non-derivative | IndirectSee Footnotes | 0 |
Reported balance
After 2021-12-08 transaction · row 3
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 3 · 2021-12-08 · Sale · Disposed 3,630,740 · Balance 0 F1: On December 8, 2021, Thermo Fisher Scientific Inc., a Delaware corporation ("Buyer"), acquired the Issuer pursuant to a certain Agreement and Plan of Merger entered into by and among the Issuer, Buyer and Powder Acquisition Corp., a Delaware corporation and wholly-owned subsidiary of Buyer ("Merger Sub"), dated as of April 15, 2021 (the "Merger Agreement"). In accordance with the Merger Agreement, the Issuer merged with and into Merger Sub, with the Issuer surviving such merger as a wholly-owned subsidiary of Buyer (the "Merger"). At the effective time of the Merger, each issued and outstanding share of the Issuer's common stock (other than certain excluded shares) automatically converted into the right to receive $47.50 in cash. F4: Reflects securities directly held by HFCP VII (Parallel-A), L.P. ("HFCP VII Parallel-A"). F11: Hellman & Friedman Investors VII, L.P. ("H&F Investors VII") is the general partner of each of the H&F VII Funds. H&F Corporate Investors VII, Ltd. ("H&F VII") is the general partner of H&F Investors VII. Hellman & Friedman Investors VIII, L.P. ("H&F Investors VIII") is the general partner of each of the H&F VIII Funds. H&F Corporate Investors VIII, Ltd. ("H&F VIII") is the general partner of H&F Investors VIII. A three member board of directors of each of H&F VII and H&F VIII has investment discretion over the shares held by the H&F VII Funds and the H&F VIII Funds, respectively. Allen R. Thorpe, a member of the board of directors of PPD, Inc. is a member of the boards of directors of H&F VII and H&F VIII. |
| Common StockSEC Table I · non-derivative | IndirectSee Footnotes | 0 |
Reported balance
After 2021-12-08 transaction · row 4
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 4 · 2021-12-08 · Sale · Disposed 359,372 · Balance 0 F1: On December 8, 2021, Thermo Fisher Scientific Inc., a Delaware corporation ("Buyer"), acquired the Issuer pursuant to a certain Agreement and Plan of Merger entered into by and among the Issuer, Buyer and Powder Acquisition Corp., a Delaware corporation and wholly-owned subsidiary of Buyer ("Merger Sub"), dated as of April 15, 2021 (the "Merger Agreement"). In accordance with the Merger Agreement, the Issuer merged with and into Merger Sub, with the Issuer surviving such merger as a wholly-owned subsidiary of Buyer (the "Merger"). At the effective time of the Merger, each issued and outstanding share of the Issuer's common stock (other than certain excluded shares) automatically converted into the right to receive $47.50 in cash. F5: Reflects securities directly held by H&F Executives VII, L.P. ("H&F VII Executives", and together with HFCP VII, HFCP VII Parallel and HFCP VII Parallel-A, the "H&F VII Funds"). F11: Hellman & Friedman Investors VII, L.P. ("H&F Investors VII") is the general partner of each of the H&F VII Funds. H&F Corporate Investors VII, Ltd. ("H&F VII") is the general partner of H&F Investors VII. Hellman & Friedman Investors VIII, L.P. ("H&F Investors VIII") is the general partner of each of the H&F VIII Funds. H&F Corporate Investors VIII, Ltd. ("H&F VIII") is the general partner of H&F Investors VIII. A three member board of directors of each of H&F VII and H&F VIII has investment discretion over the shares held by the H&F VII Funds and the H&F VIII Funds, respectively. Allen R. Thorpe, a member of the board of directors of PPD, Inc. is a member of the boards of directors of H&F VII and H&F VIII. |
| Common StockSEC Table I · non-derivative | IndirectSee Footnotes | 0 |
Reported balance
After 2021-12-08 transaction · row 5
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 5 · 2021-12-08 · Sale · Disposed 35,622,429 · Balance 0 F1: On December 8, 2021, Thermo Fisher Scientific Inc., a Delaware corporation ("Buyer"), acquired the Issuer pursuant to a certain Agreement and Plan of Merger entered into by and among the Issuer, Buyer and Powder Acquisition Corp., a Delaware corporation and wholly-owned subsidiary of Buyer ("Merger Sub"), dated as of April 15, 2021 (the "Merger Agreement"). In accordance with the Merger Agreement, the Issuer merged with and into Merger Sub, with the Issuer surviving such merger as a wholly-owned subsidiary of Buyer (the "Merger"). At the effective time of the Merger, each issued and outstanding share of the Issuer's common stock (other than certain excluded shares) automatically converted into the right to receive $47.50 in cash. F6: Reflects securities directly held by Hellman & Friedman Capital Partners VIII, L.P. ("HFCP VIII"). F11: Hellman & Friedman Investors VII, L.P. ("H&F Investors VII") is the general partner of each of the H&F VII Funds. H&F Corporate Investors VII, Ltd. ("H&F VII") is the general partner of H&F Investors VII. Hellman & Friedman Investors VIII, L.P. ("H&F Investors VIII") is the general partner of each of the H&F VIII Funds. H&F Corporate Investors VIII, Ltd. ("H&F VIII") is the general partner of H&F Investors VIII. A three member board of directors of each of H&F VII and H&F VIII has investment discretion over the shares held by the H&F VII Funds and the H&F VIII Funds, respectively. Allen R. Thorpe, a member of the board of directors of PPD, Inc. is a member of the boards of directors of H&F VII and H&F VIII. |
| Common StockSEC Table I · non-derivative | IndirectSee Footnotes | 0 |
Reported balance
After 2021-12-08 transaction · row 6
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 6 · 2021-12-08 · Sale · Disposed 15,987,409 · Balance 0 F1: On December 8, 2021, Thermo Fisher Scientific Inc., a Delaware corporation ("Buyer"), acquired the Issuer pursuant to a certain Agreement and Plan of Merger entered into by and among the Issuer, Buyer and Powder Acquisition Corp., a Delaware corporation and wholly-owned subsidiary of Buyer ("Merger Sub"), dated as of April 15, 2021 (the "Merger Agreement"). In accordance with the Merger Agreement, the Issuer merged with and into Merger Sub, with the Issuer surviving such merger as a wholly-owned subsidiary of Buyer (the "Merger"). At the effective time of the Merger, each issued and outstanding share of the Issuer's common stock (other than certain excluded shares) automatically converted into the right to receive $47.50 in cash. F7: Reflects securities directly held by Hellman & Friedman Capital Partners VIII (Parallel), L.P. ("HFCP VIII Parallel"). F11: Hellman & Friedman Investors VII, L.P. ("H&F Investors VII") is the general partner of each of the H&F VII Funds. H&F Corporate Investors VII, Ltd. ("H&F VII") is the general partner of H&F Investors VII. Hellman & Friedman Investors VIII, L.P. ("H&F Investors VIII") is the general partner of each of the H&F VIII Funds. H&F Corporate Investors VIII, Ltd. ("H&F VIII") is the general partner of H&F Investors VIII. A three member board of directors of each of H&F VII and H&F VIII has investment discretion over the shares held by the H&F VII Funds and the H&F VIII Funds, respectively. Allen R. Thorpe, a member of the board of directors of PPD, Inc. is a member of the boards of directors of H&F VII and H&F VIII. |
| Common StockSEC Table I · non-derivative | IndirectSee Footnotes | 0 |
Reported balance
After 2021-12-08 transaction · row 7
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 7 · 2021-12-08 · Sale · Disposed 3,021,286 · Balance 0 F1: On December 8, 2021, Thermo Fisher Scientific Inc., a Delaware corporation ("Buyer"), acquired the Issuer pursuant to a certain Agreement and Plan of Merger entered into by and among the Issuer, Buyer and Powder Acquisition Corp., a Delaware corporation and wholly-owned subsidiary of Buyer ("Merger Sub"), dated as of April 15, 2021 (the "Merger Agreement"). In accordance with the Merger Agreement, the Issuer merged with and into Merger Sub, with the Issuer surviving such merger as a wholly-owned subsidiary of Buyer (the "Merger"). At the effective time of the Merger, each issued and outstanding share of the Issuer's common stock (other than certain excluded shares) automatically converted into the right to receive $47.50 in cash. F8: Reflects securities directly held by HFCP VIII (Parallel-A), L.P. ("HFCP VIII Parallel-A"). F11: Hellman & Friedman Investors VII, L.P. ("H&F Investors VII") is the general partner of each of the H&F VII Funds. H&F Corporate Investors VII, Ltd. ("H&F VII") is the general partner of H&F Investors VII. Hellman & Friedman Investors VIII, L.P. ("H&F Investors VIII") is the general partner of each of the H&F VIII Funds. H&F Corporate Investors VIII, Ltd. ("H&F VIII") is the general partner of H&F Investors VIII. A three member board of directors of each of H&F VII and H&F VIII has investment discretion over the shares held by the H&F VII Funds and the H&F VIII Funds, respectively. Allen R. Thorpe, a member of the board of directors of PPD, Inc. is a member of the boards of directors of H&F VII and H&F VIII. |
| Common StockSEC Table I · non-derivative | IndirectSee Footnotes | 0 |
Reported balance
After 2021-12-08 transaction · row 8
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 8 · 2021-12-08 · Sale · Disposed 934,469 · Balance 0 F1: On December 8, 2021, Thermo Fisher Scientific Inc., a Delaware corporation ("Buyer"), acquired the Issuer pursuant to a certain Agreement and Plan of Merger entered into by and among the Issuer, Buyer and Powder Acquisition Corp., a Delaware corporation and wholly-owned subsidiary of Buyer ("Merger Sub"), dated as of April 15, 2021 (the "Merger Agreement"). In accordance with the Merger Agreement, the Issuer merged with and into Merger Sub, with the Issuer surviving such merger as a wholly-owned subsidiary of Buyer (the "Merger"). At the effective time of the Merger, each issued and outstanding share of the Issuer's common stock (other than certain excluded shares) automatically converted into the right to receive $47.50 in cash. F9: Reflects securities directly held by H&F Executives VIII, L.P. ("H&F VIII Executives"). F11: Hellman & Friedman Investors VII, L.P. ("H&F Investors VII") is the general partner of each of the H&F VII Funds. H&F Corporate Investors VII, Ltd. ("H&F VII") is the general partner of H&F Investors VII. Hellman & Friedman Investors VIII, L.P. ("H&F Investors VIII") is the general partner of each of the H&F VIII Funds. H&F Corporate Investors VIII, Ltd. ("H&F VIII") is the general partner of H&F Investors VIII. A three member board of directors of each of H&F VII and H&F VIII has investment discretion over the shares held by the H&F VII Funds and the H&F VIII Funds, respectively. Allen R. Thorpe, a member of the board of directors of PPD, Inc. is a member of the boards of directors of H&F VII and H&F VIII. |
| Common StockSEC Table I · non-derivative | IndirectSee Footnotes | 0 |
Reported balance
After 2021-12-08 transaction · row 9
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 9 · 2021-12-08 · Sale · Disposed 157,138 · Balance 0 F1: On December 8, 2021, Thermo Fisher Scientific Inc., a Delaware corporation ("Buyer"), acquired the Issuer pursuant to a certain Agreement and Plan of Merger entered into by and among the Issuer, Buyer and Powder Acquisition Corp., a Delaware corporation and wholly-owned subsidiary of Buyer ("Merger Sub"), dated as of April 15, 2021 (the "Merger Agreement"). In accordance with the Merger Agreement, the Issuer merged with and into Merger Sub, with the Issuer surviving such merger as a wholly-owned subsidiary of Buyer (the "Merger"). At the effective time of the Merger, each issued and outstanding share of the Issuer's common stock (other than certain excluded shares) automatically converted into the right to receive $47.50 in cash. F10: Reflects securities directly held by H&F Associates VIII, L.P. ("H&F VIII Associates", and together with HFCP VIII, HFCP VIII Parallel, HFCP VIII Parallel-A and H&F VIII Executives, the "H&F VIII Funds"). F11: Hellman & Friedman Investors VII, L.P. ("H&F Investors VII") is the general partner of each of the H&F VII Funds. H&F Corporate Investors VII, Ltd. ("H&F VII") is the general partner of H&F Investors VII. Hellman & Friedman Investors VIII, L.P. ("H&F Investors VIII") is the general partner of each of the H&F VIII Funds. H&F Corporate Investors VIII, Ltd. ("H&F VIII") is the general partner of H&F Investors VIII. A three member board of directors of each of H&F VII and H&F VIII has investment discretion over the shares held by the H&F VII Funds and the H&F VIII Funds, respectively. Allen R. Thorpe, a member of the board of directors of PPD, Inc. is a member of the boards of directors of H&F VII and H&F VIII. |
Filing footnotes · ownership attribution and instrument terms
F1: On December 8, 2021, Thermo Fisher Scientific Inc., a Delaware corporation ("Buyer"), acquired the Issuer pursuant to a certain Agreement and Plan of Merger entered into by and among the Issuer, Buyer and Powder Acquisition Corp., a Delaware corporation and wholly-owned subsidiary of Buyer ("Merger Sub"), dated as of April 15, 2021 (the "Merger Agreement"). In accordance with the Merger Agreement, the Issuer merged with and into Merger Sub, with the Issuer surviving such merger as a wholly-owned subsidiary of Buyer (the "Merger"). At the effective time of the Merger, each issued and outstanding share of the Issuer's common stock (other than certain excluded shares) automatically converted into the right to receive $47.50 in cash.
F2: Reflects securities directly held by Hellman & Friedman Capital Partners VII, L.P. ("HFCP VII").
F3: Reflects securities directly held by Hellman & Friedman Capital Partners VII (Parallel), L.P. ("HFCP VII Parallel").
F4: Reflects securities directly held by HFCP VII (Parallel-A), L.P. ("HFCP VII Parallel-A").
F5: Reflects securities directly held by H&F Executives VII, L.P. ("H&F VII Executives", and together with HFCP VII, HFCP VII Parallel and HFCP VII Parallel-A, the "H&F VII Funds").
F6: Reflects securities directly held by Hellman & Friedman Capital Partners VIII, L.P. ("HFCP VIII").
F7: Reflects securities directly held by Hellman & Friedman Capital Partners VIII (Parallel), L.P. ("HFCP VIII Parallel").
F8: Reflects securities directly held by HFCP VIII (Parallel-A), L.P. ("HFCP VIII Parallel-A").
F9: Reflects securities directly held by H&F Executives VIII, L.P. ("H&F VIII Executives").
F10: Reflects securities directly held by H&F Associates VIII, L.P. ("H&F VIII Associates", and together with HFCP VIII, HFCP VIII Parallel, HFCP VIII Parallel-A and H&F VIII Executives, the "H&F VIII Funds").
F11: Hellman & Friedman Investors VII, L.P. ("H&F Investors VII") is the general partner of each of the H&F VII Funds. H&F Corporate Investors VII, Ltd. ("H&F VII") is the general partner of H&F Investors VII. Hellman & Friedman Investors VIII, L.P. ("H&F Investors VIII") is the general partner of each of the H&F VIII Funds. H&F Corporate Investors VIII, Ltd. ("H&F VIII") is the general partner of H&F Investors VIII. A three member board of directors of each of H&F VII and H&F VIII has investment discretion over the shares held by the H&F VII Funds and the H&F VIII Funds, respectively. Allen R. Thorpe, a member of the board of directors of PPD, Inc. is a member of the boards of directors of H&F VII and H&F VIII.
Snap One Holdings Corp.
Report date June 14, 2024 · Filed June 14, 2024
Jointly reported with H&F Corporate Investors VIII, Ltd., Hellman & Friedman Capital Partners VIII, L.P., Hellman & Friedman Capital Partners VIII (Parallel), L.P., HFCP VIII (Parallel - A), L.P., H&F Executives VIII, L.P., H&F Associates VIII, L.P., H&F Copper Holdings VIII, L.P., H&F Copper Holdings VIII GP, LLC
Section 16 reporting ended · disclosed 2024-06-14. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | IndirectSee Footnotes | 0 |
Reported balance
After 2024-06-14 transaction · row 1
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 1 · 2024-06-14 · Other · Disposed 23,854,976 · Balance 0 F1: On June 14, 2024, Resideo Technologies, Inc. ("Resideo") acquired the Issuer pursuant to an Agreement and Plan of Merger, dated as of April 14, 2024 (the "Merger Agreement"), by and among the Issuer, Resideo and Pop Acquisition Inc., a Delaware corporation and a wholly owned subsidiary of Resideo ("Merger Sub"). In accordance with the Merger Agreement, Merger Sub merged with and into the Issuer (the "Merger") with the Issuer surviving the Merger as a wholly owned subsidiary of Resideo. At the Effective Time (as defined in the Merger Agreement), each issued and outstanding share of Issuer common stock, par value $0.01 per share (the "Common Stock") (other than certain Excluded Shares (as defined in the Merger Agreement)) automatically converted into the right to receive $10.75 per share in cash, without interest and less any applicable withholding taxes. F2: Reflects securities directly held by Hellman & Friedman Capital Partners VIII, L.P. ("HFCP VIII"). F8: Hellman & Friedman Investors VIII, L.P. ("H&F Investors VIII") is the general partner of each of the H&F VIII Funds. H&F Corporate Investors VIII, Ltd. ("H&F VIII") is the general partner of H&F Investors VIII. A three member board of directors of H&F VIII has investment discretion over the shares held by the H&F VIII Funds and Copper Holdings. Each of the members of the board of directors disclaims beneficial ownership of such shares, except to the extent of any respective pecuniary interest therein. |
| Common StockSEC Table I · non-derivative | IndirectSee Footnotes | 0 |
Reported balance
After 2024-06-14 transaction · row 2
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 2 · 2024-06-14 · Other · Disposed 10,706,163 · Balance 0 F1: On June 14, 2024, Resideo Technologies, Inc. ("Resideo") acquired the Issuer pursuant to an Agreement and Plan of Merger, dated as of April 14, 2024 (the "Merger Agreement"), by and among the Issuer, Resideo and Pop Acquisition Inc., a Delaware corporation and a wholly owned subsidiary of Resideo ("Merger Sub"). In accordance with the Merger Agreement, Merger Sub merged with and into the Issuer (the "Merger") with the Issuer surviving the Merger as a wholly owned subsidiary of Resideo. At the Effective Time (as defined in the Merger Agreement), each issued and outstanding share of Issuer common stock, par value $0.01 per share (the "Common Stock") (other than certain Excluded Shares (as defined in the Merger Agreement)) automatically converted into the right to receive $10.75 per share in cash, without interest and less any applicable withholding taxes. F3: Reflects securities directly held by Hellman & Friedman Capital Partners VIII (Parallel), L.P. ("HFCP VIII Parallel"). F8: Hellman & Friedman Investors VIII, L.P. ("H&F Investors VIII") is the general partner of each of the H&F VIII Funds. H&F Corporate Investors VIII, Ltd. ("H&F VIII") is the general partner of H&F Investors VIII. A three member board of directors of H&F VIII has investment discretion over the shares held by the H&F VIII Funds and Copper Holdings. Each of the members of the board of directors disclaims beneficial ownership of such shares, except to the extent of any respective pecuniary interest therein. |
| Common StockSEC Table I · non-derivative | IndirectSee Footnotes | 0 |
Reported balance
After 2024-06-14 transaction · row 3
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 3 · 2024-06-14 · Other · Disposed 2,023,312 · Balance 0 F1: On June 14, 2024, Resideo Technologies, Inc. ("Resideo") acquired the Issuer pursuant to an Agreement and Plan of Merger, dated as of April 14, 2024 (the "Merger Agreement"), by and among the Issuer, Resideo and Pop Acquisition Inc., a Delaware corporation and a wholly owned subsidiary of Resideo ("Merger Sub"). In accordance with the Merger Agreement, Merger Sub merged with and into the Issuer (the "Merger") with the Issuer surviving the Merger as a wholly owned subsidiary of Resideo. At the Effective Time (as defined in the Merger Agreement), each issued and outstanding share of Issuer common stock, par value $0.01 per share (the "Common Stock") (other than certain Excluded Shares (as defined in the Merger Agreement)) automatically converted into the right to receive $10.75 per share in cash, without interest and less any applicable withholding taxes. F4: Reflects securities directly held by HFCP VIII (Parallel-A), L.P. ("HFCP VIII Parallel-A"). F8: Hellman & Friedman Investors VIII, L.P. ("H&F Investors VIII") is the general partner of each of the H&F VIII Funds. H&F Corporate Investors VIII, Ltd. ("H&F VIII") is the general partner of H&F Investors VIII. A three member board of directors of H&F VIII has investment discretion over the shares held by the H&F VIII Funds and Copper Holdings. Each of the members of the board of directors disclaims beneficial ownership of such shares, except to the extent of any respective pecuniary interest therein. |
| Common StockSEC Table I · non-derivative | IndirectSee Footnotes | 0 |
Reported balance
After 2024-06-14 transaction · row 4
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 4 · 2024-06-14 · Other · Disposed 607,517 · Balance 0 F1: On June 14, 2024, Resideo Technologies, Inc. ("Resideo") acquired the Issuer pursuant to an Agreement and Plan of Merger, dated as of April 14, 2024 (the "Merger Agreement"), by and among the Issuer, Resideo and Pop Acquisition Inc., a Delaware corporation and a wholly owned subsidiary of Resideo ("Merger Sub"). In accordance with the Merger Agreement, Merger Sub merged with and into the Issuer (the "Merger") with the Issuer surviving the Merger as a wholly owned subsidiary of Resideo. At the Effective Time (as defined in the Merger Agreement), each issued and outstanding share of Issuer common stock, par value $0.01 per share (the "Common Stock") (other than certain Excluded Shares (as defined in the Merger Agreement)) automatically converted into the right to receive $10.75 per share in cash, without interest and less any applicable withholding taxes. F5: Reflects securities directly held by H&F Executives VIII, L.P. ("H&F VIII Executives"). F8: Hellman & Friedman Investors VIII, L.P. ("H&F Investors VIII") is the general partner of each of the H&F VIII Funds. H&F Corporate Investors VIII, Ltd. ("H&F VIII") is the general partner of H&F Investors VIII. A three member board of directors of H&F VIII has investment discretion over the shares held by the H&F VIII Funds and Copper Holdings. Each of the members of the board of directors disclaims beneficial ownership of such shares, except to the extent of any respective pecuniary interest therein. |
| Common StockSEC Table I · non-derivative | IndirectSee Footnotes | 0 |
Reported balance
After 2024-06-14 transaction · row 5
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 5 · 2024-06-14 · Other · Disposed 124,638 · Balance 0 F1: On June 14, 2024, Resideo Technologies, Inc. ("Resideo") acquired the Issuer pursuant to an Agreement and Plan of Merger, dated as of April 14, 2024 (the "Merger Agreement"), by and among the Issuer, Resideo and Pop Acquisition Inc., a Delaware corporation and a wholly owned subsidiary of Resideo ("Merger Sub"). In accordance with the Merger Agreement, Merger Sub merged with and into the Issuer (the "Merger") with the Issuer surviving the Merger as a wholly owned subsidiary of Resideo. At the Effective Time (as defined in the Merger Agreement), each issued and outstanding share of Issuer common stock, par value $0.01 per share (the "Common Stock") (other than certain Excluded Shares (as defined in the Merger Agreement)) automatically converted into the right to receive $10.75 per share in cash, without interest and less any applicable withholding taxes. F6: Reflects securities directly held by H&F Associates VIII, L.P. ("H&F VIII Associates", and together with HFCP VIII, HFCP VIII Parallel, HFCP VIII Parallel-A and H&F VIII Executives, the "H&F VIII Funds"). F8: Hellman & Friedman Investors VIII, L.P. ("H&F Investors VIII") is the general partner of each of the H&F VIII Funds. H&F Corporate Investors VIII, Ltd. ("H&F VIII") is the general partner of H&F Investors VIII. A three member board of directors of H&F VIII has investment discretion over the shares held by the H&F VIII Funds and Copper Holdings. Each of the members of the board of directors disclaims beneficial ownership of such shares, except to the extent of any respective pecuniary interest therein. |
| Common StockSEC Table I · non-derivative | IndirectSee Footnotes | 0 |
Reported balance
After 2024-06-14 transaction · row 6
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 6 · 2024-06-14 · Other · Disposed 18,107,829 · Balance 0 F1: On June 14, 2024, Resideo Technologies, Inc. ("Resideo") acquired the Issuer pursuant to an Agreement and Plan of Merger, dated as of April 14, 2024 (the "Merger Agreement"), by and among the Issuer, Resideo and Pop Acquisition Inc., a Delaware corporation and a wholly owned subsidiary of Resideo ("Merger Sub"). In accordance with the Merger Agreement, Merger Sub merged with and into the Issuer (the "Merger") with the Issuer surviving the Merger as a wholly owned subsidiary of Resideo. At the Effective Time (as defined in the Merger Agreement), each issued and outstanding share of Issuer common stock, par value $0.01 per share (the "Common Stock") (other than certain Excluded Shares (as defined in the Merger Agreement)) automatically converted into the right to receive $10.75 per share in cash, without interest and less any applicable withholding taxes. F7: Reflects securities directly held by H&F Copper Holdings VIII, L.P. ("Copper Holdings"), the general partner of which is H&F Copper Holdings VIII GP, LLC, the managing member of which is HFCP VIII. F8: Hellman & Friedman Investors VIII, L.P. ("H&F Investors VIII") is the general partner of each of the H&F VIII Funds. H&F Corporate Investors VIII, Ltd. ("H&F VIII") is the general partner of H&F Investors VIII. A three member board of directors of H&F VIII has investment discretion over the shares held by the H&F VIII Funds and Copper Holdings. Each of the members of the board of directors disclaims beneficial ownership of such shares, except to the extent of any respective pecuniary interest therein. |
Filing footnotes · ownership attribution and instrument terms
F1: On June 14, 2024, Resideo Technologies, Inc. ("Resideo") acquired the Issuer pursuant to an Agreement and Plan of Merger, dated as of April 14, 2024 (the "Merger Agreement"), by and among the Issuer, Resideo and Pop Acquisition Inc., a Delaware corporation and a wholly owned subsidiary of Resideo ("Merger Sub"). In accordance with the Merger Agreement, Merger Sub merged with and into the Issuer (the "Merger") with the Issuer surviving the Merger as a wholly owned subsidiary of Resideo. At the Effective Time (as defined in the Merger Agreement), each issued and outstanding share of Issuer common stock, par value $0.01 per share (the "Common Stock") (other than certain Excluded Shares (as defined in the Merger Agreement)) automatically converted into the right to receive $10.75 per share in cash, without interest and less any applicable withholding taxes.
F2: Reflects securities directly held by Hellman & Friedman Capital Partners VIII, L.P. ("HFCP VIII").
F3: Reflects securities directly held by Hellman & Friedman Capital Partners VIII (Parallel), L.P. ("HFCP VIII Parallel").
F4: Reflects securities directly held by HFCP VIII (Parallel-A), L.P. ("HFCP VIII Parallel-A").
F5: Reflects securities directly held by H&F Executives VIII, L.P. ("H&F VIII Executives").
F6: Reflects securities directly held by H&F Associates VIII, L.P. ("H&F VIII Associates", and together with HFCP VIII, HFCP VIII Parallel, HFCP VIII Parallel-A and H&F VIII Executives, the "H&F VIII Funds").
F7: Reflects securities directly held by H&F Copper Holdings VIII, L.P. ("Copper Holdings"), the general partner of which is H&F Copper Holdings VIII GP, LLC, the managing member of which is HFCP VIII.
F8: Hellman & Friedman Investors VIII, L.P. ("H&F Investors VIII") is the general partner of each of the H&F VIII Funds. H&F Corporate Investors VIII, Ltd. ("H&F VIII") is the general partner of H&F Investors VIII. A three member board of directors of H&F VIII has investment discretion over the shares held by the H&F VIII Funds and Copper Holdings. Each of the members of the board of directors disclaims beneficial ownership of such shares, except to the extent of any respective pecuniary interest therein.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| November 12, 2025 Filed Nov 14, 2025 21:30 UTC | Claritev Corp CTEV · Entity 5238 | SaleClass A Common Stock | 264,336 | $48.67 | $12,864,572.28 |
DisclosureSEC source: 0001193125-25-283138 · ownership.xml · nonDerivative · entry 6 H&F Corporate Investors VIII, Ltd. · CIK 0001767563 · 10% owner Hellman & Friedman Investors VIII, L.P. · CIK 0001801252 · 10% owner Hellman & Friedman Capital Partners VIII, L.P. · CIK 0001618933 · 10% owner Hellman & Friedman Capital Partners VIII (Parallel), L.P. · CIK 0001618902 · 10% owner HFCP VIII (Parallel - A), L.P. · CIK 0001618909 · 10% owner H&F Executives VIII, L.P. · CIK 0001619367 · 10% owner H&F Associates VIII, L.P. · CIK 0001621509 · 10% owner H&F Polaris Partners, L.P. · CIK 0001677346 · 10% owner H&F Polaris Partners GP, LLC · CIK 0001827933 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnotes Disclosed balance after: 677,590 F1 · price: The shares of Class A common stock were sold in connection with an underwritten public offering of the Issuer. The shares were sold at a price per share equal to the public offering price, net of underwriting discounts and commissions. F7 · ownership.nature: Represents shares sold directly by H&F Polaris Partners, L.P. ("Polaris Partners"), the general partner of which is H&F Polaris Partners GP, LLC, the managing member of which is HFCP VIII. F8 · ownership.nature: Hellman & Friedman Investors VIII, L.P. ("H&F Investors VIII") is the general partner of each of the H&F VIII Funds. H&F Corporate Investors VIII, Ltd. ("H&F VIII") is the general partner of H&F Investors VIII. A three member board of directors of H&F VIII has investment discretion over the shares held by the H&F VIII Funds and Polaris Partners. The Reporting Persons states that this filing shall not be an admission that the Reporting Persons are the beneficial owners of any of the securities reported herein, and each Reporting Person disclaims beneficial ownership of such securities except to the extent of such Reporting Person's pecuniary interest therein. Read SEC document |
| November 12, 2025 Filed Nov 14, 2025 21:30 UTC | Claritev Corp CTEV · Entity 5238 | SaleClass A Common Stock | 3,485 | $48.67 | $169,606.24 |
DisclosureSEC source: 0001193125-25-283138 · ownership.xml · nonDerivative · entry 5 H&F Corporate Investors VIII, Ltd. · CIK 0001767563 · 10% owner Hellman & Friedman Investors VIII, L.P. · CIK 0001801252 · 10% owner Hellman & Friedman Capital Partners VIII, L.P. · CIK 0001618933 · 10% owner Hellman & Friedman Capital Partners VIII (Parallel), L.P. · CIK 0001618902 · 10% owner HFCP VIII (Parallel - A), L.P. · CIK 0001618909 · 10% owner H&F Executives VIII, L.P. · CIK 0001619367 · 10% owner H&F Associates VIII, L.P. · CIK 0001621509 · 10% owner H&F Polaris Partners, L.P. · CIK 0001677346 · 10% owner H&F Polaris Partners GP, LLC · CIK 0001827933 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnotes Disclosed balance after: 8,932 F1 · price: The shares of Class A common stock were sold in connection with an underwritten public offering of the Issuer. The shares were sold at a price per share equal to the public offering price, net of underwriting discounts and commissions. F6 · ownership.nature: Represents shares sold directly by H&F Associates VIII, L.P. ("H&F VIII Associates", and together with HFCP VIII, HFCP VIII Parallel, HFCP VIII Parallel-A and H&F VIII Executives, the "H&F VIII Funds"). F8 · ownership.nature: Hellman & Friedman Investors VIII, L.P. ("H&F Investors VIII") is the general partner of each of the H&F VIII Funds. H&F Corporate Investors VIII, Ltd. ("H&F VIII") is the general partner of H&F Investors VIII. A three member board of directors of H&F VIII has investment discretion over the shares held by the H&F VIII Funds and Polaris Partners. The Reporting Persons states that this filing shall not be an admission that the Reporting Persons are the beneficial owners of any of the securities reported herein, and each Reporting Person disclaims beneficial ownership of such securities except to the extent of such Reporting Person's pecuniary interest therein. Read SEC document |
| November 12, 2025 Filed Nov 14, 2025 21:30 UTC | Claritev Corp CTEV · Entity 5238 | SaleClass A Common Stock | 20,722 | $48.67 | $1,008,487.94 |
DisclosureSEC source: 0001193125-25-283138 · ownership.xml · nonDerivative · entry 4 H&F Corporate Investors VIII, Ltd. · CIK 0001767563 · 10% owner Hellman & Friedman Investors VIII, L.P. · CIK 0001801252 · 10% owner Hellman & Friedman Capital Partners VIII, L.P. · CIK 0001618933 · 10% owner Hellman & Friedman Capital Partners VIII (Parallel), L.P. · CIK 0001618902 · 10% owner HFCP VIII (Parallel - A), L.P. · CIK 0001618909 · 10% owner H&F Executives VIII, L.P. · CIK 0001619367 · 10% owner H&F Associates VIII, L.P. · CIK 0001621509 · 10% owner H&F Polaris Partners, L.P. · CIK 0001677346 · 10% owner H&F Polaris Partners GP, LLC · CIK 0001827933 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnotes Disclosed balance after: 53,118 F1 · price: The shares of Class A common stock were sold in connection with an underwritten public offering of the Issuer. The shares were sold at a price per share equal to the public offering price, net of underwriting discounts and commissions. F5 · ownership.nature: Represents shares sold directly by H&F Executives VIII, L.P. ("H&F VIII Executives"). F8 · ownership.nature: Hellman & Friedman Investors VIII, L.P. ("H&F Investors VIII") is the general partner of each of the H&F VIII Funds. H&F Corporate Investors VIII, Ltd. ("H&F VIII") is the general partner of H&F Investors VIII. A three member board of directors of H&F VIII has investment discretion over the shares held by the H&F VIII Funds and Polaris Partners. The Reporting Persons states that this filing shall not be an admission that the Reporting Persons are the beneficial owners of any of the securities reported herein, and each Reporting Person disclaims beneficial ownership of such securities except to the extent of such Reporting Person's pecuniary interest therein. Read SEC document |
| November 12, 2025 Filed Nov 14, 2025 21:30 UTC | Claritev Corp CTEV · Entity 5238 | SaleClass A Common Stock | 66,997 | $48.67 | $3,260,576.50 |
DisclosureSEC source: 0001193125-25-283138 · ownership.xml · nonDerivative · entry 3 H&F Corporate Investors VIII, Ltd. · CIK 0001767563 · 10% owner Hellman & Friedman Investors VIII, L.P. · CIK 0001801252 · 10% owner Hellman & Friedman Capital Partners VIII, L.P. · CIK 0001618933 · 10% owner Hellman & Friedman Capital Partners VIII (Parallel), L.P. · CIK 0001618902 · 10% owner HFCP VIII (Parallel - A), L.P. · CIK 0001618909 · 10% owner H&F Executives VIII, L.P. · CIK 0001619367 · 10% owner H&F Associates VIII, L.P. · CIK 0001621509 · 10% owner H&F Polaris Partners, L.P. · CIK 0001677346 · 10% owner H&F Polaris Partners GP, LLC · CIK 0001827933 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnotes Disclosed balance after: 171,740 F1 · price: The shares of Class A common stock were sold in connection with an underwritten public offering of the Issuer. The shares were sold at a price per share equal to the public offering price, net of underwriting discounts and commissions. F4 · ownership.nature: Represents shares sold directly by HFCP VIII Parallel-A ("HFCP VIII Parallel-A"). F8 · ownership.nature: Hellman & Friedman Investors VIII, L.P. ("H&F Investors VIII") is the general partner of each of the H&F VIII Funds. H&F Corporate Investors VIII, Ltd. ("H&F VIII") is the general partner of H&F Investors VIII. A three member board of directors of H&F VIII has investment discretion over the shares held by the H&F VIII Funds and Polaris Partners. The Reporting Persons states that this filing shall not be an admission that the Reporting Persons are the beneficial owners of any of the securities reported herein, and each Reporting Person disclaims beneficial ownership of such securities except to the extent of such Reporting Person's pecuniary interest therein. Read SEC document |
| November 12, 2025 Filed Nov 14, 2025 21:30 UTC | Claritev Corp CTEV · Entity 5238 | SaleClass A Common Stock | 354,524 | $48.67 | $17,253,796.77 |
DisclosureSEC source: 0001193125-25-283138 · ownership.xml · nonDerivative · entry 2 H&F Corporate Investors VIII, Ltd. · CIK 0001767563 · 10% owner Hellman & Friedman Investors VIII, L.P. · CIK 0001801252 · 10% owner Hellman & Friedman Capital Partners VIII, L.P. · CIK 0001618933 · 10% owner Hellman & Friedman Capital Partners VIII (Parallel), L.P. · CIK 0001618902 · 10% owner HFCP VIII (Parallel - A), L.P. · CIK 0001618909 · 10% owner H&F Executives VIII, L.P. · CIK 0001619367 · 10% owner H&F Associates VIII, L.P. · CIK 0001621509 · 10% owner H&F Polaris Partners, L.P. · CIK 0001677346 · 10% owner H&F Polaris Partners GP, LLC · CIK 0001827933 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnotes Disclosed balance after: 908,778 F1 · price: The shares of Class A common stock were sold in connection with an underwritten public offering of the Issuer. The shares were sold at a price per share equal to the public offering price, net of underwriting discounts and commissions. F3 · ownership.nature: Represents shares sold directly by Hellman & Friedman Capital Partners VIII (Parallel), L.P. ("HFCP VIII Parallel"). F8 · ownership.nature: Hellman & Friedman Investors VIII, L.P. ("H&F Investors VIII") is the general partner of each of the H&F VIII Funds. H&F Corporate Investors VIII, Ltd. ("H&F VIII") is the general partner of H&F Investors VIII. A three member board of directors of H&F VIII has investment discretion over the shares held by the H&F VIII Funds and Polaris Partners. The Reporting Persons states that this filing shall not be an admission that the Reporting Persons are the beneficial owners of any of the securities reported herein, and each Reporting Person disclaims beneficial ownership of such securities except to the extent of such Reporting Person's pecuniary interest therein. Read SEC document |
| November 12, 2025 Filed Nov 14, 2025 21:30 UTC | Claritev Corp CTEV · Entity 5238 | SaleClass A Common Stock | 789,936 | $48.67 | $38,444,210.28 |
DisclosureSEC source: 0001193125-25-283138 · ownership.xml · nonDerivative · entry 1 H&F Corporate Investors VIII, Ltd. · CIK 0001767563 · 10% owner Hellman & Friedman Investors VIII, L.P. · CIK 0001801252 · 10% owner Hellman & Friedman Capital Partners VIII, L.P. · CIK 0001618933 · 10% owner Hellman & Friedman Capital Partners VIII (Parallel), L.P. · CIK 0001618902 · 10% owner HFCP VIII (Parallel - A), L.P. · CIK 0001618909 · 10% owner H&F Executives VIII, L.P. · CIK 0001619367 · 10% owner H&F Associates VIII, L.P. · CIK 0001621509 · 10% owner H&F Polaris Partners, L.P. · CIK 0001677346 · 10% owner H&F Polaris Partners GP, LLC · CIK 0001827933 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnotes Disclosed balance after: 2,024,899 F1 · price: The shares of Class A common stock were sold in connection with an underwritten public offering of the Issuer. The shares were sold at a price per share equal to the public offering price, net of underwriting discounts and commissions. F2 · ownership.nature: Represents shares sold directly by Hellman & Friedman Capital Partners VIII, L.P. ("HFCP VIII"). F8 · ownership.nature: Hellman & Friedman Investors VIII, L.P. ("H&F Investors VIII") is the general partner of each of the H&F VIII Funds. H&F Corporate Investors VIII, Ltd. ("H&F VIII") is the general partner of H&F Investors VIII. A three member board of directors of H&F VIII has investment discretion over the shares held by the H&F VIII Funds and Polaris Partners. The Reporting Persons states that this filing shall not be an admission that the Reporting Persons are the beneficial owners of any of the securities reported herein, and each Reporting Person disclaims beneficial ownership of such securities except to the extent of such Reporting Person's pecuniary interest therein. Read SEC document |
| June 14, 2024 Filed Jun 14, 2024 17:00 UTC | Snap One Holdings Corp. SNPO · Entity 89862 | OtherCommon Stock | 18,107,829 | $10.75 | $194,659,161.75 |
DisclosureSEC source: 0000950170-24-073773 · ownership.xml · nonDerivative · entry 6 H&F Corporate Investors VIII, Ltd. · CIK 0001767563 · 10% owner Hellman & Friedman Investors VIII, L.P. · CIK 0001801252 · 10% owner Hellman & Friedman Capital Partners VIII, L.P. · CIK 0001618933 · 10% owner Hellman & Friedman Capital Partners VIII (Parallel), L.P. · CIK 0001618902 · 10% owner HFCP VIII (Parallel - A), L.P. · CIK 0001618909 · 10% owner H&F Executives VIII, L.P. · CIK 0001619367 · 10% owner H&F Associates VIII, L.P. · CIK 0001621509 · 10% owner H&F Copper Holdings VIII, L.P. · CIK 0001871642 · 10% owner H&F Copper Holdings VIII GP, LLC · CIK 0001871641 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnotes Disclosed balance after: 0 F1 · kind: On June 14, 2024, Resideo Technologies, Inc. ("Resideo") acquired the Issuer pursuant to an Agreement and Plan of Merger, dated as of April 14, 2024 (the "Merger Agreement"), by and among the Issuer, Resideo and Pop Acquisition Inc., a Delaware corporation and a wholly owned subsidiary of Resideo ("Merger Sub"). In accordance with the Merger Agreement, Merger Sub merged with and into the Issuer (the "Merger") with the Issuer surviving the Merger as a wholly owned subsidiary of Resideo. At the Effective Time (as defined in the Merger Agreement), each issued and outstanding share of Issuer common stock, par value $0.01 per share (the "Common Stock") (other than certain Excluded Shares (as defined in the Merger Agreement)) automatically converted into the right to receive $10.75 per share in cash, without interest and less any applicable withholding taxes. F1 · price: On June 14, 2024, Resideo Technologies, Inc. ("Resideo") acquired the Issuer pursuant to an Agreement and Plan of Merger, dated as of April 14, 2024 (the "Merger Agreement"), by and among the Issuer, Resideo and Pop Acquisition Inc., a Delaware corporation and a wholly owned subsidiary of Resideo ("Merger Sub"). In accordance with the Merger Agreement, Merger Sub merged with and into the Issuer (the "Merger") with the Issuer surviving the Merger as a wholly owned subsidiary of Resideo. At the Effective Time (as defined in the Merger Agreement), each issued and outstanding share of Issuer common stock, par value $0.01 per share (the "Common Stock") (other than certain Excluded Shares (as defined in the Merger Agreement)) automatically converted into the right to receive $10.75 per share in cash, without interest and less any applicable withholding taxes. F7 · ownership.nature: Reflects securities directly held by H&F Copper Holdings VIII, L.P. ("Copper Holdings"), the general partner of which is H&F Copper Holdings VIII GP, LLC, the managing member of which is HFCP VIII. F8 · ownership.nature: Hellman & Friedman Investors VIII, L.P. ("H&F Investors VIII") is the general partner of each of the H&F VIII Funds. H&F Corporate Investors VIII, Ltd. ("H&F VIII") is the general partner of H&F Investors VIII. A three member board of directors of H&F VIII has investment discretion over the shares held by the H&F VIII Funds and Copper Holdings. Each of the members of the board of directors disclaims beneficial ownership of such shares, except to the extent of any respective pecuniary interest therein. Read SEC document |
| June 14, 2024 Filed Jun 14, 2024 17:00 UTC | Snap One Holdings Corp. SNPO · Entity 89862 | OtherCommon Stock | 124,638 | $10.75 | $1,339,858.50 |
DisclosureSEC source: 0000950170-24-073773 · ownership.xml · nonDerivative · entry 5 H&F Corporate Investors VIII, Ltd. · CIK 0001767563 · 10% owner Hellman & Friedman Investors VIII, L.P. · CIK 0001801252 · 10% owner Hellman & Friedman Capital Partners VIII, L.P. · CIK 0001618933 · 10% owner Hellman & Friedman Capital Partners VIII (Parallel), L.P. · CIK 0001618902 · 10% owner HFCP VIII (Parallel - A), L.P. · CIK 0001618909 · 10% owner H&F Executives VIII, L.P. · CIK 0001619367 · 10% owner H&F Associates VIII, L.P. · CIK 0001621509 · 10% owner H&F Copper Holdings VIII, L.P. · CIK 0001871642 · 10% owner H&F Copper Holdings VIII GP, LLC · CIK 0001871641 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnotes Disclosed balance after: 0 F1 · kind: On June 14, 2024, Resideo Technologies, Inc. ("Resideo") acquired the Issuer pursuant to an Agreement and Plan of Merger, dated as of April 14, 2024 (the "Merger Agreement"), by and among the Issuer, Resideo and Pop Acquisition Inc., a Delaware corporation and a wholly owned subsidiary of Resideo ("Merger Sub"). In accordance with the Merger Agreement, Merger Sub merged with and into the Issuer (the "Merger") with the Issuer surviving the Merger as a wholly owned subsidiary of Resideo. At the Effective Time (as defined in the Merger Agreement), each issued and outstanding share of Issuer common stock, par value $0.01 per share (the "Common Stock") (other than certain Excluded Shares (as defined in the Merger Agreement)) automatically converted into the right to receive $10.75 per share in cash, without interest and less any applicable withholding taxes. F1 · price: On June 14, 2024, Resideo Technologies, Inc. ("Resideo") acquired the Issuer pursuant to an Agreement and Plan of Merger, dated as of April 14, 2024 (the "Merger Agreement"), by and among the Issuer, Resideo and Pop Acquisition Inc., a Delaware corporation and a wholly owned subsidiary of Resideo ("Merger Sub"). In accordance with the Merger Agreement, Merger Sub merged with and into the Issuer (the "Merger") with the Issuer surviving the Merger as a wholly owned subsidiary of Resideo. At the Effective Time (as defined in the Merger Agreement), each issued and outstanding share of Issuer common stock, par value $0.01 per share (the "Common Stock") (other than certain Excluded Shares (as defined in the Merger Agreement)) automatically converted into the right to receive $10.75 per share in cash, without interest and less any applicable withholding taxes. F6 · ownership.nature: Reflects securities directly held by H&F Associates VIII, L.P. ("H&F VIII Associates", and together with HFCP VIII, HFCP VIII Parallel, HFCP VIII Parallel-A and H&F VIII Executives, the "H&F VIII Funds"). F8 · ownership.nature: Hellman & Friedman Investors VIII, L.P. ("H&F Investors VIII") is the general partner of each of the H&F VIII Funds. H&F Corporate Investors VIII, Ltd. ("H&F VIII") is the general partner of H&F Investors VIII. A three member board of directors of H&F VIII has investment discretion over the shares held by the H&F VIII Funds and Copper Holdings. Each of the members of the board of directors disclaims beneficial ownership of such shares, except to the extent of any respective pecuniary interest therein. Read SEC document |
| June 14, 2024 Filed Jun 14, 2024 17:00 UTC | Snap One Holdings Corp. SNPO · Entity 89862 | OtherCommon Stock | 607,517 | $10.75 | $6,530,807.75 |
DisclosureSEC source: 0000950170-24-073773 · ownership.xml · nonDerivative · entry 4 H&F Corporate Investors VIII, Ltd. · CIK 0001767563 · 10% owner Hellman & Friedman Investors VIII, L.P. · CIK 0001801252 · 10% owner Hellman & Friedman Capital Partners VIII, L.P. · CIK 0001618933 · 10% owner Hellman & Friedman Capital Partners VIII (Parallel), L.P. · CIK 0001618902 · 10% owner HFCP VIII (Parallel - A), L.P. · CIK 0001618909 · 10% owner H&F Executives VIII, L.P. · CIK 0001619367 · 10% owner H&F Associates VIII, L.P. · CIK 0001621509 · 10% owner H&F Copper Holdings VIII, L.P. · CIK 0001871642 · 10% owner H&F Copper Holdings VIII GP, LLC · CIK 0001871641 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnotes Disclosed balance after: 0 F1 · kind: On June 14, 2024, Resideo Technologies, Inc. ("Resideo") acquired the Issuer pursuant to an Agreement and Plan of Merger, dated as of April 14, 2024 (the "Merger Agreement"), by and among the Issuer, Resideo and Pop Acquisition Inc., a Delaware corporation and a wholly owned subsidiary of Resideo ("Merger Sub"). In accordance with the Merger Agreement, Merger Sub merged with and into the Issuer (the "Merger") with the Issuer surviving the Merger as a wholly owned subsidiary of Resideo. At the Effective Time (as defined in the Merger Agreement), each issued and outstanding share of Issuer common stock, par value $0.01 per share (the "Common Stock") (other than certain Excluded Shares (as defined in the Merger Agreement)) automatically converted into the right to receive $10.75 per share in cash, without interest and less any applicable withholding taxes. F1 · price: On June 14, 2024, Resideo Technologies, Inc. ("Resideo") acquired the Issuer pursuant to an Agreement and Plan of Merger, dated as of April 14, 2024 (the "Merger Agreement"), by and among the Issuer, Resideo and Pop Acquisition Inc., a Delaware corporation and a wholly owned subsidiary of Resideo ("Merger Sub"). In accordance with the Merger Agreement, Merger Sub merged with and into the Issuer (the "Merger") with the Issuer surviving the Merger as a wholly owned subsidiary of Resideo. At the Effective Time (as defined in the Merger Agreement), each issued and outstanding share of Issuer common stock, par value $0.01 per share (the "Common Stock") (other than certain Excluded Shares (as defined in the Merger Agreement)) automatically converted into the right to receive $10.75 per share in cash, without interest and less any applicable withholding taxes. F5 · ownership.nature: Reflects securities directly held by H&F Executives VIII, L.P. ("H&F VIII Executives"). F8 · ownership.nature: Hellman & Friedman Investors VIII, L.P. ("H&F Investors VIII") is the general partner of each of the H&F VIII Funds. H&F Corporate Investors VIII, Ltd. ("H&F VIII") is the general partner of H&F Investors VIII. A three member board of directors of H&F VIII has investment discretion over the shares held by the H&F VIII Funds and Copper Holdings. Each of the members of the board of directors disclaims beneficial ownership of such shares, except to the extent of any respective pecuniary interest therein. Read SEC document |
| June 14, 2024 Filed Jun 14, 2024 17:00 UTC | Snap One Holdings Corp. SNPO · Entity 89862 | OtherCommon Stock | 2,023,312 | $10.75 | $21,750,604.00 |
DisclosureSEC source: 0000950170-24-073773 · ownership.xml · nonDerivative · entry 3 H&F Corporate Investors VIII, Ltd. · CIK 0001767563 · 10% owner Hellman & Friedman Investors VIII, L.P. · CIK 0001801252 · 10% owner Hellman & Friedman Capital Partners VIII, L.P. · CIK 0001618933 · 10% owner Hellman & Friedman Capital Partners VIII (Parallel), L.P. · CIK 0001618902 · 10% owner HFCP VIII (Parallel - A), L.P. · CIK 0001618909 · 10% owner H&F Executives VIII, L.P. · CIK 0001619367 · 10% owner H&F Associates VIII, L.P. · CIK 0001621509 · 10% owner H&F Copper Holdings VIII, L.P. · CIK 0001871642 · 10% owner H&F Copper Holdings VIII GP, LLC · CIK 0001871641 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnotes Disclosed balance after: 0 F1 · kind: On June 14, 2024, Resideo Technologies, Inc. ("Resideo") acquired the Issuer pursuant to an Agreement and Plan of Merger, dated as of April 14, 2024 (the "Merger Agreement"), by and among the Issuer, Resideo and Pop Acquisition Inc., a Delaware corporation and a wholly owned subsidiary of Resideo ("Merger Sub"). In accordance with the Merger Agreement, Merger Sub merged with and into the Issuer (the "Merger") with the Issuer surviving the Merger as a wholly owned subsidiary of Resideo. At the Effective Time (as defined in the Merger Agreement), each issued and outstanding share of Issuer common stock, par value $0.01 per share (the "Common Stock") (other than certain Excluded Shares (as defined in the Merger Agreement)) automatically converted into the right to receive $10.75 per share in cash, without interest and less any applicable withholding taxes. F1 · price: On June 14, 2024, Resideo Technologies, Inc. ("Resideo") acquired the Issuer pursuant to an Agreement and Plan of Merger, dated as of April 14, 2024 (the "Merger Agreement"), by and among the Issuer, Resideo and Pop Acquisition Inc., a Delaware corporation and a wholly owned subsidiary of Resideo ("Merger Sub"). In accordance with the Merger Agreement, Merger Sub merged with and into the Issuer (the "Merger") with the Issuer surviving the Merger as a wholly owned subsidiary of Resideo. At the Effective Time (as defined in the Merger Agreement), each issued and outstanding share of Issuer common stock, par value $0.01 per share (the "Common Stock") (other than certain Excluded Shares (as defined in the Merger Agreement)) automatically converted into the right to receive $10.75 per share in cash, without interest and less any applicable withholding taxes. F4 · ownership.nature: Reflects securities directly held by HFCP VIII (Parallel-A), L.P. ("HFCP VIII Parallel-A"). F8 · ownership.nature: Hellman & Friedman Investors VIII, L.P. ("H&F Investors VIII") is the general partner of each of the H&F VIII Funds. H&F Corporate Investors VIII, Ltd. ("H&F VIII") is the general partner of H&F Investors VIII. A three member board of directors of H&F VIII has investment discretion over the shares held by the H&F VIII Funds and Copper Holdings. Each of the members of the board of directors disclaims beneficial ownership of such shares, except to the extent of any respective pecuniary interest therein. Read SEC document |
| June 14, 2024 Filed Jun 14, 2024 17:00 UTC | Snap One Holdings Corp. SNPO · Entity 89862 | OtherCommon Stock | 10,706,163 | $10.75 | $115,091,252.25 |
DisclosureSEC source: 0000950170-24-073773 · ownership.xml · nonDerivative · entry 2 H&F Corporate Investors VIII, Ltd. · CIK 0001767563 · 10% owner Hellman & Friedman Investors VIII, L.P. · CIK 0001801252 · 10% owner Hellman & Friedman Capital Partners VIII, L.P. · CIK 0001618933 · 10% owner Hellman & Friedman Capital Partners VIII (Parallel), L.P. · CIK 0001618902 · 10% owner HFCP VIII (Parallel - A), L.P. · CIK 0001618909 · 10% owner H&F Executives VIII, L.P. · CIK 0001619367 · 10% owner H&F Associates VIII, L.P. · CIK 0001621509 · 10% owner H&F Copper Holdings VIII, L.P. · CIK 0001871642 · 10% owner H&F Copper Holdings VIII GP, LLC · CIK 0001871641 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnotes Disclosed balance after: 0 F1 · kind: On June 14, 2024, Resideo Technologies, Inc. ("Resideo") acquired the Issuer pursuant to an Agreement and Plan of Merger, dated as of April 14, 2024 (the "Merger Agreement"), by and among the Issuer, Resideo and Pop Acquisition Inc., a Delaware corporation and a wholly owned subsidiary of Resideo ("Merger Sub"). In accordance with the Merger Agreement, Merger Sub merged with and into the Issuer (the "Merger") with the Issuer surviving the Merger as a wholly owned subsidiary of Resideo. At the Effective Time (as defined in the Merger Agreement), each issued and outstanding share of Issuer common stock, par value $0.01 per share (the "Common Stock") (other than certain Excluded Shares (as defined in the Merger Agreement)) automatically converted into the right to receive $10.75 per share in cash, without interest and less any applicable withholding taxes. F1 · price: On June 14, 2024, Resideo Technologies, Inc. ("Resideo") acquired the Issuer pursuant to an Agreement and Plan of Merger, dated as of April 14, 2024 (the "Merger Agreement"), by and among the Issuer, Resideo and Pop Acquisition Inc., a Delaware corporation and a wholly owned subsidiary of Resideo ("Merger Sub"). In accordance with the Merger Agreement, Merger Sub merged with and into the Issuer (the "Merger") with the Issuer surviving the Merger as a wholly owned subsidiary of Resideo. At the Effective Time (as defined in the Merger Agreement), each issued and outstanding share of Issuer common stock, par value $0.01 per share (the "Common Stock") (other than certain Excluded Shares (as defined in the Merger Agreement)) automatically converted into the right to receive $10.75 per share in cash, without interest and less any applicable withholding taxes. F3 · ownership.nature: Reflects securities directly held by Hellman & Friedman Capital Partners VIII (Parallel), L.P. ("HFCP VIII Parallel"). F8 · ownership.nature: Hellman & Friedman Investors VIII, L.P. ("H&F Investors VIII") is the general partner of each of the H&F VIII Funds. H&F Corporate Investors VIII, Ltd. ("H&F VIII") is the general partner of H&F Investors VIII. A three member board of directors of H&F VIII has investment discretion over the shares held by the H&F VIII Funds and Copper Holdings. Each of the members of the board of directors disclaims beneficial ownership of such shares, except to the extent of any respective pecuniary interest therein. Read SEC document |
| June 14, 2024 Filed Jun 14, 2024 17:00 UTC | Snap One Holdings Corp. SNPO · Entity 89862 | OtherCommon Stock | 23,854,976 | $10.75 | $256,440,992.00 |
DisclosureSEC source: 0000950170-24-073773 · ownership.xml · nonDerivative · entry 1 H&F Corporate Investors VIII, Ltd. · CIK 0001767563 · 10% owner Hellman & Friedman Investors VIII, L.P. · CIK 0001801252 · 10% owner Hellman & Friedman Capital Partners VIII, L.P. · CIK 0001618933 · 10% owner Hellman & Friedman Capital Partners VIII (Parallel), L.P. · CIK 0001618902 · 10% owner HFCP VIII (Parallel - A), L.P. · CIK 0001618909 · 10% owner H&F Executives VIII, L.P. · CIK 0001619367 · 10% owner H&F Associates VIII, L.P. · CIK 0001621509 · 10% owner H&F Copper Holdings VIII, L.P. · CIK 0001871642 · 10% owner H&F Copper Holdings VIII GP, LLC · CIK 0001871641 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnotes Disclosed balance after: 0 F1 · kind: On June 14, 2024, Resideo Technologies, Inc. ("Resideo") acquired the Issuer pursuant to an Agreement and Plan of Merger, dated as of April 14, 2024 (the "Merger Agreement"), by and among the Issuer, Resideo and Pop Acquisition Inc., a Delaware corporation and a wholly owned subsidiary of Resideo ("Merger Sub"). In accordance with the Merger Agreement, Merger Sub merged with and into the Issuer (the "Merger") with the Issuer surviving the Merger as a wholly owned subsidiary of Resideo. At the Effective Time (as defined in the Merger Agreement), each issued and outstanding share of Issuer common stock, par value $0.01 per share (the "Common Stock") (other than certain Excluded Shares (as defined in the Merger Agreement)) automatically converted into the right to receive $10.75 per share in cash, without interest and less any applicable withholding taxes. F1 · price: On June 14, 2024, Resideo Technologies, Inc. ("Resideo") acquired the Issuer pursuant to an Agreement and Plan of Merger, dated as of April 14, 2024 (the "Merger Agreement"), by and among the Issuer, Resideo and Pop Acquisition Inc., a Delaware corporation and a wholly owned subsidiary of Resideo ("Merger Sub"). In accordance with the Merger Agreement, Merger Sub merged with and into the Issuer (the "Merger") with the Issuer surviving the Merger as a wholly owned subsidiary of Resideo. At the Effective Time (as defined in the Merger Agreement), each issued and outstanding share of Issuer common stock, par value $0.01 per share (the "Common Stock") (other than certain Excluded Shares (as defined in the Merger Agreement)) automatically converted into the right to receive $10.75 per share in cash, without interest and less any applicable withholding taxes. F2 · ownership.nature: Reflects securities directly held by Hellman & Friedman Capital Partners VIII, L.P. ("HFCP VIII"). F8 · ownership.nature: Hellman & Friedman Investors VIII, L.P. ("H&F Investors VIII") is the general partner of each of the H&F VIII Funds. H&F Corporate Investors VIII, Ltd. ("H&F VIII") is the general partner of H&F Investors VIII. A three member board of directors of H&F VIII has investment discretion over the shares held by the H&F VIII Funds and Copper Holdings. Each of the members of the board of directors disclaims beneficial ownership of such shares, except to the extent of any respective pecuniary interest therein. Read SEC document |
| December 08, 2021 Filed Dec 8, 2021 22:05 UTC | PPD, Inc. PPD · Entity 15247 | SaleCommon Stock | 157,138 | $47.50 | $7,464,055.00 |
DisclosureSEC source: 0000899243-21-047360 · doc4.xml · nonDerivative · entry 9 H&F Corporate Investors VIII, Ltd. · CIK 0001767563 · 10% owner Hellman & Friedman Investors VIII, L.P. · CIK 0001801252 · 10% owner Hellman & Friedman Capital Partners VIII, L.P. · CIK 0001618933 · 10% owner Hellman & Friedman Capital Partners VIII (Parallel), L.P. · CIK 0001618902 · 10% owner HFCP VIII (Parallel - A), L.P. · CIK 0001618909 · 10% owner H&F Executives VIII, L.P. · CIK 0001619367 · 10% owner H&F Associates VIII, L.P. · CIK 0001621509 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes Disclosed balance after: 0 F1 · kind: On December 8, 2021, Thermo Fisher Scientific Inc., a Delaware corporation ("Buyer"), acquired the Issuer pursuant to a certain Agreement and Plan of Merger entered into by and among the Issuer, Buyer and Powder Acquisition Corp., a Delaware corporation and wholly-owned subsidiary of Buyer ("Merger Sub"), dated as of April 15, 2021 (the "Merger Agreement"). In accordance with the Merger Agreement, the Issuer merged with and into Merger Sub, with the Issuer surviving such merger as a wholly-owned subsidiary of Buyer (the "Merger"). At the effective time of the Merger, each issued and outstanding share of the Issuer's common stock (other than certain excluded shares) automatically converted into the right to receive $47.50 in cash. F10 · ownership.nature: Reflects securities directly held by H&F Associates VIII, L.P. ("H&F VIII Associates", and together with HFCP VIII, HFCP VIII Parallel, HFCP VIII Parallel-A and H&F VIII Executives, the "H&F VIII Funds"). F11 · ownership.nature: Hellman & Friedman Investors VII, L.P. ("H&F Investors VII") is the general partner of each of the H&F VII Funds. H&F Corporate Investors VII, Ltd. ("H&F VII") is the general partner of H&F Investors VII. Hellman & Friedman Investors VIII, L.P. ("H&F Investors VIII") is the general partner of each of the H&F VIII Funds. H&F Corporate Investors VIII, Ltd. ("H&F VIII") is the general partner of H&F Investors VIII. A three member board of directors of each of H&F VII and H&F VIII has investment discretion over the shares held by the H&F VII Funds and the H&F VIII Funds, respectively. Allen R. Thorpe, a member of the board of directors of PPD, Inc. is a member of the boards of directors of H&F VII and H&F VIII. Read SEC document |
| December 08, 2021 Filed Dec 8, 2021 22:05 UTC | PPD, Inc. PPD · Entity 15247 | SaleCommon Stock | 934,469 | $47.50 | $44,387,277.50 |
DisclosureSEC source: 0000899243-21-047360 · doc4.xml · nonDerivative · entry 8 H&F Corporate Investors VIII, Ltd. · CIK 0001767563 · 10% owner Hellman & Friedman Investors VIII, L.P. · CIK 0001801252 · 10% owner Hellman & Friedman Capital Partners VIII, L.P. · CIK 0001618933 · 10% owner Hellman & Friedman Capital Partners VIII (Parallel), L.P. · CIK 0001618902 · 10% owner HFCP VIII (Parallel - A), L.P. · CIK 0001618909 · 10% owner H&F Executives VIII, L.P. · CIK 0001619367 · 10% owner H&F Associates VIII, L.P. · CIK 0001621509 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes Disclosed balance after: 0 F1 · kind: On December 8, 2021, Thermo Fisher Scientific Inc., a Delaware corporation ("Buyer"), acquired the Issuer pursuant to a certain Agreement and Plan of Merger entered into by and among the Issuer, Buyer and Powder Acquisition Corp., a Delaware corporation and wholly-owned subsidiary of Buyer ("Merger Sub"), dated as of April 15, 2021 (the "Merger Agreement"). In accordance with the Merger Agreement, the Issuer merged with and into Merger Sub, with the Issuer surviving such merger as a wholly-owned subsidiary of Buyer (the "Merger"). At the effective time of the Merger, each issued and outstanding share of the Issuer's common stock (other than certain excluded shares) automatically converted into the right to receive $47.50 in cash. F9 · ownership.nature: Reflects securities directly held by H&F Executives VIII, L.P. ("H&F VIII Executives"). F11 · ownership.nature: Hellman & Friedman Investors VII, L.P. ("H&F Investors VII") is the general partner of each of the H&F VII Funds. H&F Corporate Investors VII, Ltd. ("H&F VII") is the general partner of H&F Investors VII. Hellman & Friedman Investors VIII, L.P. ("H&F Investors VIII") is the general partner of each of the H&F VIII Funds. H&F Corporate Investors VIII, Ltd. ("H&F VIII") is the general partner of H&F Investors VIII. A three member board of directors of each of H&F VII and H&F VIII has investment discretion over the shares held by the H&F VII Funds and the H&F VIII Funds, respectively. Allen R. Thorpe, a member of the board of directors of PPD, Inc. is a member of the boards of directors of H&F VII and H&F VIII. Read SEC document |
| December 08, 2021 Filed Dec 8, 2021 22:05 UTC | PPD, Inc. PPD · Entity 15247 | SaleCommon Stock | 3,021,286 | $47.50 | $143,511,085.00 |
DisclosureSEC source: 0000899243-21-047360 · doc4.xml · nonDerivative · entry 7 H&F Corporate Investors VIII, Ltd. · CIK 0001767563 · 10% owner Hellman & Friedman Investors VIII, L.P. · CIK 0001801252 · 10% owner Hellman & Friedman Capital Partners VIII, L.P. · CIK 0001618933 · 10% owner Hellman & Friedman Capital Partners VIII (Parallel), L.P. · CIK 0001618902 · 10% owner HFCP VIII (Parallel - A), L.P. · CIK 0001618909 · 10% owner H&F Executives VIII, L.P. · CIK 0001619367 · 10% owner H&F Associates VIII, L.P. · CIK 0001621509 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes Disclosed balance after: 0 F1 · kind: On December 8, 2021, Thermo Fisher Scientific Inc., a Delaware corporation ("Buyer"), acquired the Issuer pursuant to a certain Agreement and Plan of Merger entered into by and among the Issuer, Buyer and Powder Acquisition Corp., a Delaware corporation and wholly-owned subsidiary of Buyer ("Merger Sub"), dated as of April 15, 2021 (the "Merger Agreement"). In accordance with the Merger Agreement, the Issuer merged with and into Merger Sub, with the Issuer surviving such merger as a wholly-owned subsidiary of Buyer (the "Merger"). At the effective time of the Merger, each issued and outstanding share of the Issuer's common stock (other than certain excluded shares) automatically converted into the right to receive $47.50 in cash. F8 · ownership.nature: Reflects securities directly held by HFCP VIII (Parallel-A), L.P. ("HFCP VIII Parallel-A"). F11 · ownership.nature: Hellman & Friedman Investors VII, L.P. ("H&F Investors VII") is the general partner of each of the H&F VII Funds. H&F Corporate Investors VII, Ltd. ("H&F VII") is the general partner of H&F Investors VII. Hellman & Friedman Investors VIII, L.P. ("H&F Investors VIII") is the general partner of each of the H&F VIII Funds. H&F Corporate Investors VIII, Ltd. ("H&F VIII") is the general partner of H&F Investors VIII. A three member board of directors of each of H&F VII and H&F VIII has investment discretion over the shares held by the H&F VII Funds and the H&F VIII Funds, respectively. Allen R. Thorpe, a member of the board of directors of PPD, Inc. is a member of the boards of directors of H&F VII and H&F VIII. Read SEC document |
| December 08, 2021 Filed Dec 8, 2021 22:05 UTC | PPD, Inc. PPD · Entity 15247 | SaleCommon Stock | 15,987,409 | $47.50 | $759,401,927.50 |
DisclosureSEC source: 0000899243-21-047360 · doc4.xml · nonDerivative · entry 6 H&F Corporate Investors VIII, Ltd. · CIK 0001767563 · 10% owner Hellman & Friedman Investors VIII, L.P. · CIK 0001801252 · 10% owner Hellman & Friedman Capital Partners VIII, L.P. · CIK 0001618933 · 10% owner Hellman & Friedman Capital Partners VIII (Parallel), L.P. · CIK 0001618902 · 10% owner HFCP VIII (Parallel - A), L.P. · CIK 0001618909 · 10% owner H&F Executives VIII, L.P. · CIK 0001619367 · 10% owner H&F Associates VIII, L.P. · CIK 0001621509 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes Disclosed balance after: 0 F1 · kind: On December 8, 2021, Thermo Fisher Scientific Inc., a Delaware corporation ("Buyer"), acquired the Issuer pursuant to a certain Agreement and Plan of Merger entered into by and among the Issuer, Buyer and Powder Acquisition Corp., a Delaware corporation and wholly-owned subsidiary of Buyer ("Merger Sub"), dated as of April 15, 2021 (the "Merger Agreement"). In accordance with the Merger Agreement, the Issuer merged with and into Merger Sub, with the Issuer surviving such merger as a wholly-owned subsidiary of Buyer (the "Merger"). At the effective time of the Merger, each issued and outstanding share of the Issuer's common stock (other than certain excluded shares) automatically converted into the right to receive $47.50 in cash. F7 · ownership.nature: Reflects securities directly held by Hellman & Friedman Capital Partners VIII (Parallel), L.P. ("HFCP VIII Parallel"). F11 · ownership.nature: Hellman & Friedman Investors VII, L.P. ("H&F Investors VII") is the general partner of each of the H&F VII Funds. H&F Corporate Investors VII, Ltd. ("H&F VII") is the general partner of H&F Investors VII. Hellman & Friedman Investors VIII, L.P. ("H&F Investors VIII") is the general partner of each of the H&F VIII Funds. H&F Corporate Investors VIII, Ltd. ("H&F VIII") is the general partner of H&F Investors VIII. A three member board of directors of each of H&F VII and H&F VIII has investment discretion over the shares held by the H&F VII Funds and the H&F VIII Funds, respectively. Allen R. Thorpe, a member of the board of directors of PPD, Inc. is a member of the boards of directors of H&F VII and H&F VIII. Read SEC document |
| December 08, 2021 Filed Dec 8, 2021 22:05 UTC | PPD, Inc. PPD · Entity 15247 | SaleCommon Stock | 35,622,429 | $47.50 | $1,692,065,377.50 |
DisclosureSEC source: 0000899243-21-047360 · doc4.xml · nonDerivative · entry 5 H&F Corporate Investors VIII, Ltd. · CIK 0001767563 · 10% owner Hellman & Friedman Investors VIII, L.P. · CIK 0001801252 · 10% owner Hellman & Friedman Capital Partners VIII, L.P. · CIK 0001618933 · 10% owner Hellman & Friedman Capital Partners VIII (Parallel), L.P. · CIK 0001618902 · 10% owner HFCP VIII (Parallel - A), L.P. · CIK 0001618909 · 10% owner H&F Executives VIII, L.P. · CIK 0001619367 · 10% owner H&F Associates VIII, L.P. · CIK 0001621509 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes Disclosed balance after: 0 F1 · kind: On December 8, 2021, Thermo Fisher Scientific Inc., a Delaware corporation ("Buyer"), acquired the Issuer pursuant to a certain Agreement and Plan of Merger entered into by and among the Issuer, Buyer and Powder Acquisition Corp., a Delaware corporation and wholly-owned subsidiary of Buyer ("Merger Sub"), dated as of April 15, 2021 (the "Merger Agreement"). In accordance with the Merger Agreement, the Issuer merged with and into Merger Sub, with the Issuer surviving such merger as a wholly-owned subsidiary of Buyer (the "Merger"). At the effective time of the Merger, each issued and outstanding share of the Issuer's common stock (other than certain excluded shares) automatically converted into the right to receive $47.50 in cash. F6 · ownership.nature: Reflects securities directly held by Hellman & Friedman Capital Partners VIII, L.P. ("HFCP VIII"). F11 · ownership.nature: Hellman & Friedman Investors VII, L.P. ("H&F Investors VII") is the general partner of each of the H&F VII Funds. H&F Corporate Investors VII, Ltd. ("H&F VII") is the general partner of H&F Investors VII. Hellman & Friedman Investors VIII, L.P. ("H&F Investors VIII") is the general partner of each of the H&F VIII Funds. H&F Corporate Investors VIII, Ltd. ("H&F VIII") is the general partner of H&F Investors VIII. A three member board of directors of each of H&F VII and H&F VIII has investment discretion over the shares held by the H&F VII Funds and the H&F VIII Funds, respectively. Allen R. Thorpe, a member of the board of directors of PPD, Inc. is a member of the boards of directors of H&F VII and H&F VIII. Read SEC document |
| December 08, 2021 Filed Dec 8, 2021 22:05 UTC | PPD, Inc. PPD · Entity 15247 | SaleCommon Stock | 359,372 | $47.50 | $17,070,170.00 |
DisclosureSEC source: 0000899243-21-047360 · doc4.xml · nonDerivative · entry 4 H&F Corporate Investors VIII, Ltd. · CIK 0001767563 · 10% owner Hellman & Friedman Investors VIII, L.P. · CIK 0001801252 · 10% owner Hellman & Friedman Capital Partners VIII, L.P. · CIK 0001618933 · 10% owner Hellman & Friedman Capital Partners VIII (Parallel), L.P. · CIK 0001618902 · 10% owner HFCP VIII (Parallel - A), L.P. · CIK 0001618909 · 10% owner H&F Executives VIII, L.P. · CIK 0001619367 · 10% owner H&F Associates VIII, L.P. · CIK 0001621509 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes Disclosed balance after: 0 F1 · kind: On December 8, 2021, Thermo Fisher Scientific Inc., a Delaware corporation ("Buyer"), acquired the Issuer pursuant to a certain Agreement and Plan of Merger entered into by and among the Issuer, Buyer and Powder Acquisition Corp., a Delaware corporation and wholly-owned subsidiary of Buyer ("Merger Sub"), dated as of April 15, 2021 (the "Merger Agreement"). In accordance with the Merger Agreement, the Issuer merged with and into Merger Sub, with the Issuer surviving such merger as a wholly-owned subsidiary of Buyer (the "Merger"). At the effective time of the Merger, each issued and outstanding share of the Issuer's common stock (other than certain excluded shares) automatically converted into the right to receive $47.50 in cash. F5 · ownership.nature: Reflects securities directly held by H&F Executives VII, L.P. ("H&F VII Executives", and together with HFCP VII, HFCP VII Parallel and HFCP VII Parallel-A, the "H&F VII Funds"). F11 · ownership.nature: Hellman & Friedman Investors VII, L.P. ("H&F Investors VII") is the general partner of each of the H&F VII Funds. H&F Corporate Investors VII, Ltd. ("H&F VII") is the general partner of H&F Investors VII. Hellman & Friedman Investors VIII, L.P. ("H&F Investors VIII") is the general partner of each of the H&F VIII Funds. H&F Corporate Investors VIII, Ltd. ("H&F VIII") is the general partner of H&F Investors VIII. A three member board of directors of each of H&F VII and H&F VIII has investment discretion over the shares held by the H&F VII Funds and the H&F VIII Funds, respectively. Allen R. Thorpe, a member of the board of directors of PPD, Inc. is a member of the boards of directors of H&F VII and H&F VIII. Read SEC document |
| December 08, 2021 Filed Dec 8, 2021 22:05 UTC | PPD, Inc. PPD · Entity 15247 | SaleCommon Stock | 3,630,740 | $47.50 | $172,460,150.00 |
DisclosureSEC source: 0000899243-21-047360 · doc4.xml · nonDerivative · entry 3 H&F Corporate Investors VIII, Ltd. · CIK 0001767563 · 10% owner Hellman & Friedman Investors VIII, L.P. · CIK 0001801252 · 10% owner Hellman & Friedman Capital Partners VIII, L.P. · CIK 0001618933 · 10% owner Hellman & Friedman Capital Partners VIII (Parallel), L.P. · CIK 0001618902 · 10% owner HFCP VIII (Parallel - A), L.P. · CIK 0001618909 · 10% owner H&F Executives VIII, L.P. · CIK 0001619367 · 10% owner H&F Associates VIII, L.P. · CIK 0001621509 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes Disclosed balance after: 0 F1 · kind: On December 8, 2021, Thermo Fisher Scientific Inc., a Delaware corporation ("Buyer"), acquired the Issuer pursuant to a certain Agreement and Plan of Merger entered into by and among the Issuer, Buyer and Powder Acquisition Corp., a Delaware corporation and wholly-owned subsidiary of Buyer ("Merger Sub"), dated as of April 15, 2021 (the "Merger Agreement"). In accordance with the Merger Agreement, the Issuer merged with and into Merger Sub, with the Issuer surviving such merger as a wholly-owned subsidiary of Buyer (the "Merger"). At the effective time of the Merger, each issued and outstanding share of the Issuer's common stock (other than certain excluded shares) automatically converted into the right to receive $47.50 in cash. F4 · ownership.nature: Reflects securities directly held by HFCP VII (Parallel-A), L.P. ("HFCP VII Parallel-A"). F11 · ownership.nature: Hellman & Friedman Investors VII, L.P. ("H&F Investors VII") is the general partner of each of the H&F VII Funds. H&F Corporate Investors VII, Ltd. ("H&F VII") is the general partner of H&F Investors VII. Hellman & Friedman Investors VIII, L.P. ("H&F Investors VIII") is the general partner of each of the H&F VIII Funds. H&F Corporate Investors VIII, Ltd. ("H&F VIII") is the general partner of H&F Investors VIII. A three member board of directors of each of H&F VII and H&F VIII has investment discretion over the shares held by the H&F VII Funds and the H&F VIII Funds, respectively. Allen R. Thorpe, a member of the board of directors of PPD, Inc. is a member of the boards of directors of H&F VII and H&F VIII. Read SEC document |
| December 08, 2021 Filed Dec 8, 2021 22:05 UTC | PPD, Inc. PPD · Entity 15247 | SaleCommon Stock | 20,244,387 | $47.50 | $961,608,382.50 |
DisclosureSEC source: 0000899243-21-047360 · doc4.xml · nonDerivative · entry 2 H&F Corporate Investors VIII, Ltd. · CIK 0001767563 · 10% owner Hellman & Friedman Investors VIII, L.P. · CIK 0001801252 · 10% owner Hellman & Friedman Capital Partners VIII, L.P. · CIK 0001618933 · 10% owner Hellman & Friedman Capital Partners VIII (Parallel), L.P. · CIK 0001618902 · 10% owner HFCP VIII (Parallel - A), L.P. · CIK 0001618909 · 10% owner H&F Executives VIII, L.P. · CIK 0001619367 · 10% owner H&F Associates VIII, L.P. · CIK 0001621509 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes Disclosed balance after: 0 F1 · kind: On December 8, 2021, Thermo Fisher Scientific Inc., a Delaware corporation ("Buyer"), acquired the Issuer pursuant to a certain Agreement and Plan of Merger entered into by and among the Issuer, Buyer and Powder Acquisition Corp., a Delaware corporation and wholly-owned subsidiary of Buyer ("Merger Sub"), dated as of April 15, 2021 (the "Merger Agreement"). In accordance with the Merger Agreement, the Issuer merged with and into Merger Sub, with the Issuer surviving such merger as a wholly-owned subsidiary of Buyer (the "Merger"). At the effective time of the Merger, each issued and outstanding share of the Issuer's common stock (other than certain excluded shares) automatically converted into the right to receive $47.50 in cash. F3 · ownership.nature: Reflects securities directly held by Hellman & Friedman Capital Partners VII (Parallel), L.P. ("HFCP VII Parallel"). F11 · ownership.nature: Hellman & Friedman Investors VII, L.P. ("H&F Investors VII") is the general partner of each of the H&F VII Funds. H&F Corporate Investors VII, Ltd. ("H&F VII") is the general partner of H&F Investors VII. Hellman & Friedman Investors VIII, L.P. ("H&F Investors VIII") is the general partner of each of the H&F VIII Funds. H&F Corporate Investors VIII, Ltd. ("H&F VIII") is the general partner of H&F Investors VIII. A three member board of directors of each of H&F VII and H&F VIII has investment discretion over the shares held by the H&F VII Funds and the H&F VIII Funds, respectively. Allen R. Thorpe, a member of the board of directors of PPD, Inc. is a member of the boards of directors of H&F VII and H&F VIII. Read SEC document |
| December 08, 2021 Filed Dec 8, 2021 22:05 UTC | PPD, Inc. PPD · Entity 15247 | SaleCommon Stock | 52,884,036 | $47.50 | $2,511,991,710.00 |
DisclosureSEC source: 0000899243-21-047360 · doc4.xml · nonDerivative · entry 1 H&F Corporate Investors VIII, Ltd. · CIK 0001767563 · 10% owner Hellman & Friedman Investors VIII, L.P. · CIK 0001801252 · 10% owner Hellman & Friedman Capital Partners VIII, L.P. · CIK 0001618933 · 10% owner Hellman & Friedman Capital Partners VIII (Parallel), L.P. · CIK 0001618902 · 10% owner HFCP VIII (Parallel - A), L.P. · CIK 0001618909 · 10% owner H&F Executives VIII, L.P. · CIK 0001619367 · 10% owner H&F Associates VIII, L.P. · CIK 0001621509 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes Disclosed balance after: 0 F1 · kind: On December 8, 2021, Thermo Fisher Scientific Inc., a Delaware corporation ("Buyer"), acquired the Issuer pursuant to a certain Agreement and Plan of Merger entered into by and among the Issuer, Buyer and Powder Acquisition Corp., a Delaware corporation and wholly-owned subsidiary of Buyer ("Merger Sub"), dated as of April 15, 2021 (the "Merger Agreement"). In accordance with the Merger Agreement, the Issuer merged with and into Merger Sub, with the Issuer surviving such merger as a wholly-owned subsidiary of Buyer (the "Merger"). At the effective time of the Merger, each issued and outstanding share of the Issuer's common stock (other than certain excluded shares) automatically converted into the right to receive $47.50 in cash. F2 · ownership.nature: Reflects securities directly held by Hellman & Friedman Capital Partners VII, L.P. ("HFCP VII"). F11 · ownership.nature: Hellman & Friedman Investors VII, L.P. ("H&F Investors VII") is the general partner of each of the H&F VII Funds. H&F Corporate Investors VII, Ltd. ("H&F VII") is the general partner of H&F Investors VII. Hellman & Friedman Investors VIII, L.P. ("H&F Investors VIII") is the general partner of each of the H&F VIII Funds. H&F Corporate Investors VIII, Ltd. ("H&F VIII") is the general partner of H&F Investors VIII. A three member board of directors of each of H&F VII and H&F VIII has investment discretion over the shares held by the H&F VII Funds and the H&F VIII Funds, respectively. Allen R. Thorpe, a member of the board of directors of PPD, Inc. is a member of the boards of directors of H&F VII and H&F VIII. Read SEC document |
| December 07, 2020 Filed Dec 8, 2020 11:06 UTC | Claritev Corp MPLN · Entity 5238 | PurchaseClass A common stock | 1,597,324 | $8.34 | $13,329,029.85 |
DisclosureSEC source: 0000899243-20-032967 · doc4.xml · nonDerivative · entry 2 H&F Corporate Investors VIII, Ltd. · CIK 0001767563 · 10% owner Hellman & Friedman Investors VIII, L.P. · CIK 0001801252 · 10% owner HFCP VIII (Parallel - A), L.P. · CIK 0001618909 · 10% owner Music Investments, L.P. · CIK 0001834598 · 10% owner Music Investments GP, LLC · CIK 0001834610 · 10% owner Thorpe Allen R · CIK 0001405076 · Director Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes Disclosed balance after: 1,712,045 F2 · price: Represents shares of Class A common stock purchased in multiple transactions at prices ranging from $8.12 to $8.66. The price reported is a weighted average price. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares of Class A common stock purchased at each separate price within the range set forth in this footnote (2). F3 · ownership.nature: Reflects securities directly held by Music Investments, L.P., the general partner of which is Music Investments GP, LLC, the managing member of which is HFCP VIII (Parallel-A), L.P. ("HFCP VIII Parallel-A"). F10 · ownership.nature: Hellman & Friedman Investors VIII, L.P. ("H&F Investors VIII") is the general partner of each of the H&F VIII Funds. H&F Corporate Investors VIII, Ltd. ("H&F VIII") is the general partner of H&F Investors VIII. A three member board of directors of H&F VIII has investment discretion over the shares held by the H&F VIII Funds and Polaris Partners. Allen R. Thorpe, a member of the board of directors of MultiPlan Corporation is a member of the board of directors of H&F VIII. Read SEC document |
| December 04, 2020 Filed Dec 8, 2020 11:06 UTC | Claritev Corp MPLN · Entity 5238 | PurchaseClass A common stock | 114,721 | $7.54 | $864,571.87 |
DisclosureSEC source: 0000899243-20-032967 · doc4.xml · nonDerivative · entry 1 H&F Corporate Investors VIII, Ltd. · CIK 0001767563 · 10% owner Hellman & Friedman Investors VIII, L.P. · CIK 0001801252 · 10% owner HFCP VIII (Parallel - A), L.P. · CIK 0001618909 · 10% owner Music Investments, L.P. · CIK 0001834598 · 10% owner Music Investments GP, LLC · CIK 0001834610 · 10% owner Thorpe Allen R · CIK 0001405076 · Director Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes Disclosed balance after: 114,721 F1 · price: Represents shares of Class A common stock purchased in multiple transactions at prices ranging from $7.465 to $7.70. The price reported is a weighted average price. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares of Class A common stock purchased at each separate price within the range set forth in this footnote (1). F3 · ownership.nature: Reflects securities directly held by Music Investments, L.P., the general partner of which is Music Investments GP, LLC, the managing member of which is HFCP VIII (Parallel-A), L.P. ("HFCP VIII Parallel-A"). F10 · ownership.nature: Hellman & Friedman Investors VIII, L.P. ("H&F Investors VIII") is the general partner of each of the H&F VIII Funds. H&F Corporate Investors VIII, Ltd. ("H&F VIII") is the general partner of H&F Investors VIII. A three member board of directors of H&F VIII has investment discretion over the shares held by the H&F VIII Funds and Polaris Partners. Allen R. Thorpe, a member of the board of directors of MultiPlan Corporation is a member of the board of directors of H&F VIII. Read SEC document |
| September 21, 2020 Filed Sep 23, 2020 20:48 UTC | PPD, Inc. PPD · Entity 15247 | GiftCommon Stock | 127,867 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-20-026096 · doc4.xml · nonDerivative · entry 11 H&F Corporate Investors VIII, Ltd. · CIK 0001767563 · 10% owner Hellman & Friedman Investors VIII, L.P. · CIK 0001801252 · 10% owner Hellman & Friedman Capital Partners VIII, L.P. · CIK 0001618933 · 10% owner Hellman & Friedman Capital Partners VIII (Parallel), L.P. · CIK 0001618902 · 10% owner HFCP VIII (Parallel - A), L.P. · CIK 0001618909 · 10% owner H&F Executives VIII, L.P. · CIK 0001619367 · 10% owner H&F Associates VIII, L.P. · CIK 0001621509 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F13 · ownership.direct: These shares of Common Stock were received by Mr. Thorpe in connection with pro rata distributions made by HFCP VII described above and were transferred as a charitable donation upon receipt. Read SEC document |
| September 21, 2020 Filed Sep 23, 2020 20:48 UTC | PPD, Inc. PPD · Entity 15247 | SaleCommon Stock | 30,264 | $31.28 | $946,733.58 |
DisclosureSEC source: 0000899243-20-026096 · doc4.xml · nonDerivative · entry 10 H&F Corporate Investors VIII, Ltd. · CIK 0001767563 · 10% owner Hellman & Friedman Investors VIII, L.P. · CIK 0001801252 · 10% owner Hellman & Friedman Capital Partners VIII, L.P. · CIK 0001618933 · 10% owner Hellman & Friedman Capital Partners VIII (Parallel), L.P. · CIK 0001618902 · 10% owner HFCP VIII (Parallel - A), L.P. · CIK 0001618909 · 10% owner H&F Executives VIII, L.P. · CIK 0001619367 · 10% owner H&F Associates VIII, L.P. · CIK 0001621509 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes Disclosed balance after: 157,138 F1 · price: This amount represents the $32.25 secondary public offering price per share of the Common Stock of the Issuer less the underwriting discount of $0.9675 per share. F10 · ownership.nature: Reflects securities directly held by H&F Associates VIII, L.P. ("H&F VIII Associates", and together with HFCP VIII, HFCP VIII Parallel, HFCP VIII Parallel-A and H&F VIII Executives, the "H&F VIII Funds"). F11 · ownership.nature: Hellman & Friedman Investors VII, L.P. ("H&F Investors VII") is the general partner of each of the H&F VII Funds. H&F Corporate Investors VII, Ltd. ("H&F VII") is the general partner of H&F Investors VII. Hellman & Friedman Investors VIII, L.P. ("H&F Investors VIII") is the general partner of each of the H&F VIII Funds. H&F Corporate Investors VIII, Ltd. ("H&F VIII") is the general partner of H&F Investors VIII. A three member board of directors of each of H&F VII and H&F VIII has investment discretion over the shares held by the H&F VII Funds and the H&F VIII Funds, respectively. Allen R. Thorpe, a member of the board of directors of PPD, Inc. is a member of the boards of directors of H&F VII and H&F VIII. Read SEC document |
| September 21, 2020 Filed Sep 23, 2020 20:48 UTC | PPD, Inc. PPD · Entity 15247 | SaleCommon Stock | 179,980 | $31.28 | $5,630,224.35 |
DisclosureSEC source: 0000899243-20-026096 · doc4.xml · nonDerivative · entry 9 H&F Corporate Investors VIII, Ltd. · CIK 0001767563 · 10% owner Hellman & Friedman Investors VIII, L.P. · CIK 0001801252 · 10% owner Hellman & Friedman Capital Partners VIII, L.P. · CIK 0001618933 · 10% owner Hellman & Friedman Capital Partners VIII (Parallel), L.P. · CIK 0001618902 · 10% owner HFCP VIII (Parallel - A), L.P. · CIK 0001618909 · 10% owner H&F Executives VIII, L.P. · CIK 0001619367 · 10% owner H&F Associates VIII, L.P. · CIK 0001621509 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes Disclosed balance after: 934,469 F1 · price: This amount represents the $32.25 secondary public offering price per share of the Common Stock of the Issuer less the underwriting discount of $0.9675 per share. F9 · ownership.nature: Reflects securities directly held by H&F Executives VIII, L.P. ("H&F VIII Executives"). F11 · ownership.nature: Hellman & Friedman Investors VII, L.P. ("H&F Investors VII") is the general partner of each of the H&F VII Funds. H&F Corporate Investors VII, Ltd. ("H&F VII") is the general partner of H&F Investors VII. Hellman & Friedman Investors VIII, L.P. ("H&F Investors VIII") is the general partner of each of the H&F VIII Funds. H&F Corporate Investors VIII, Ltd. ("H&F VIII") is the general partner of H&F Investors VIII. A three member board of directors of each of H&F VII and H&F VIII has investment discretion over the shares held by the H&F VII Funds and the H&F VIII Funds, respectively. Allen R. Thorpe, a member of the board of directors of PPD, Inc. is a member of the boards of directors of H&F VII and H&F VIII. Read SEC document |
| September 21, 2020 Filed Sep 23, 2020 20:48 UTC | PPD, Inc. PPD · Entity 15247 | SaleCommon Stock | 581,903 | $31.28 | $18,203,380.60 |
DisclosureSEC source: 0000899243-20-026096 · doc4.xml · nonDerivative · entry 8 H&F Corporate Investors VIII, Ltd. · CIK 0001767563 · 10% owner Hellman & Friedman Investors VIII, L.P. · CIK 0001801252 · 10% owner Hellman & Friedman Capital Partners VIII, L.P. · CIK 0001618933 · 10% owner Hellman & Friedman Capital Partners VIII (Parallel), L.P. · CIK 0001618902 · 10% owner HFCP VIII (Parallel - A), L.P. · CIK 0001618909 · 10% owner H&F Executives VIII, L.P. · CIK 0001619367 · 10% owner H&F Associates VIII, L.P. · CIK 0001621509 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes Disclosed balance after: 3,021,286 F1 · price: This amount represents the $32.25 secondary public offering price per share of the Common Stock of the Issuer less the underwriting discount of $0.9675 per share. F8 · ownership.nature: Reflects securities directly held by HFCP VIII (Parallel-A), L.P. ("HFCP VIII Parallel-A"). F11 · ownership.nature: Hellman & Friedman Investors VII, L.P. ("H&F Investors VII") is the general partner of each of the H&F VII Funds. H&F Corporate Investors VII, Ltd. ("H&F VII") is the general partner of H&F Investors VII. Hellman & Friedman Investors VIII, L.P. ("H&F Investors VIII") is the general partner of each of the H&F VIII Funds. H&F Corporate Investors VIII, Ltd. ("H&F VIII") is the general partner of H&F Investors VIII. A three member board of directors of each of H&F VII and H&F VIII has investment discretion over the shares held by the H&F VII Funds and the H&F VIII Funds, respectively. Allen R. Thorpe, a member of the board of directors of PPD, Inc. is a member of the boards of directors of H&F VII and H&F VIII. Read SEC document |
| September 21, 2020 Filed Sep 23, 2020 20:48 UTC | PPD, Inc. PPD · Entity 15247 | SaleCommon Stock | 3,079,193 | $31.28 | $96,324,855.02 |
DisclosureSEC source: 0000899243-20-026096 · doc4.xml · nonDerivative · entry 7 H&F Corporate Investors VIII, Ltd. · CIK 0001767563 · 10% owner Hellman & Friedman Investors VIII, L.P. · CIK 0001801252 · 10% owner Hellman & Friedman Capital Partners VIII, L.P. · CIK 0001618933 · 10% owner Hellman & Friedman Capital Partners VIII (Parallel), L.P. · CIK 0001618902 · 10% owner HFCP VIII (Parallel - A), L.P. · CIK 0001618909 · 10% owner H&F Executives VIII, L.P. · CIK 0001619367 · 10% owner H&F Associates VIII, L.P. · CIK 0001621509 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes Disclosed balance after: 15,987,409 F1 · price: This amount represents the $32.25 secondary public offering price per share of the Common Stock of the Issuer less the underwriting discount of $0.9675 per share. F7 · ownership.nature: Reflects securities directly held by Hellman & Friedman Capital Partners VIII (Parallel), L.P. ("HFCP VIII Parallel"). F11 · ownership.nature: Hellman & Friedman Investors VII, L.P. ("H&F Investors VII") is the general partner of each of the H&F VII Funds. H&F Corporate Investors VII, Ltd. ("H&F VII") is the general partner of H&F Investors VII. Hellman & Friedman Investors VIII, L.P. ("H&F Investors VIII") is the general partner of each of the H&F VIII Funds. H&F Corporate Investors VIII, Ltd. ("H&F VIII") is the general partner of H&F Investors VIII. A three member board of directors of each of H&F VII and H&F VIII has investment discretion over the shares held by the H&F VII Funds and the H&F VIII Funds, respectively. Allen R. Thorpe, a member of the board of directors of PPD, Inc. is a member of the boards of directors of H&F VII and H&F VIII. Read SEC document |
| September 21, 2020 Filed Sep 23, 2020 20:48 UTC | PPD, Inc. PPD · Entity 15247 | SaleCommon Stock | 6,860,919 | $31.28 | $214,626,698.62 |
DisclosureSEC source: 0000899243-20-026096 · doc4.xml · nonDerivative · entry 6 H&F Corporate Investors VIII, Ltd. · CIK 0001767563 · 10% owner Hellman & Friedman Investors VIII, L.P. · CIK 0001801252 · 10% owner Hellman & Friedman Capital Partners VIII, L.P. · CIK 0001618933 · 10% owner Hellman & Friedman Capital Partners VIII (Parallel), L.P. · CIK 0001618902 · 10% owner HFCP VIII (Parallel - A), L.P. · CIK 0001618909 · 10% owner H&F Executives VIII, L.P. · CIK 0001619367 · 10% owner H&F Associates VIII, L.P. · CIK 0001621509 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes Disclosed balance after: 35,622,429 F1 · price: This amount represents the $32.25 secondary public offering price per share of the Common Stock of the Issuer less the underwriting discount of $0.9675 per share. F6 · ownership.nature: Reflects securities directly held by Hellman & Friedman Capital Partners VIII, L.P. ("HFCP VIII"). F11 · ownership.nature: Hellman & Friedman Investors VII, L.P. ("H&F Investors VII") is the general partner of each of the H&F VII Funds. H&F Corporate Investors VII, Ltd. ("H&F VII") is the general partner of H&F Investors VII. Hellman & Friedman Investors VIII, L.P. ("H&F Investors VIII") is the general partner of each of the H&F VIII Funds. H&F Corporate Investors VIII, Ltd. ("H&F VIII") is the general partner of H&F Investors VIII. A three member board of directors of each of H&F VII and H&F VIII has investment discretion over the shares held by the H&F VII Funds and the H&F VIII Funds, respectively. Allen R. Thorpe, a member of the board of directors of PPD, Inc. is a member of the boards of directors of H&F VII and H&F VIII. Read SEC document |
| September 21, 2020 Filed Sep 23, 2020 20:48 UTC | PPD, Inc. PPD · Entity 15247 | SaleCommon Stock | 69,215 | $31.28 | $2,165,218.24 |
DisclosureSEC source: 0000899243-20-026096 · doc4.xml · nonDerivative · entry 5 H&F Corporate Investors VIII, Ltd. · CIK 0001767563 · 10% owner Hellman & Friedman Investors VIII, L.P. · CIK 0001801252 · 10% owner Hellman & Friedman Capital Partners VIII, L.P. · CIK 0001618933 · 10% owner Hellman & Friedman Capital Partners VIII (Parallel), L.P. · CIK 0001618902 · 10% owner HFCP VIII (Parallel - A), L.P. · CIK 0001618909 · 10% owner H&F Executives VIII, L.P. · CIK 0001619367 · 10% owner H&F Associates VIII, L.P. · CIK 0001621509 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes Disclosed balance after: 359,372 F1 · price: This amount represents the $32.25 secondary public offering price per share of the Common Stock of the Issuer less the underwriting discount of $0.9675 per share. F5 · ownership.nature: Reflects securities directly held by H&F Executives VII, L.P. ("H&F VII Executives", and together with HFCP VII, HFCP VII Parallel and HFCP VII Parallel-A, the "H&F VII Funds"). F11 · ownership.nature: Hellman & Friedman Investors VII, L.P. ("H&F Investors VII") is the general partner of each of the H&F VII Funds. H&F Corporate Investors VII, Ltd. ("H&F VII") is the general partner of H&F Investors VII. Hellman & Friedman Investors VIII, L.P. ("H&F Investors VIII") is the general partner of each of the H&F VIII Funds. H&F Corporate Investors VIII, Ltd. ("H&F VIII") is the general partner of H&F Investors VIII. A three member board of directors of each of H&F VII and H&F VIII has investment discretion over the shares held by the H&F VII Funds and the H&F VIII Funds, respectively. Allen R. Thorpe, a member of the board of directors of PPD, Inc. is a member of the boards of directors of H&F VII and H&F VIII. Read SEC document |
| September 21, 2020 Filed Sep 23, 2020 20:48 UTC | PPD, Inc. PPD · Entity 15247 | SaleCommon Stock | 699,284 | $31.28 | $21,875,351.73 |
DisclosureSEC source: 0000899243-20-026096 · doc4.xml · nonDerivative · entry 4 H&F Corporate Investors VIII, Ltd. · CIK 0001767563 · 10% owner Hellman & Friedman Investors VIII, L.P. · CIK 0001801252 · 10% owner Hellman & Friedman Capital Partners VIII, L.P. · CIK 0001618933 · 10% owner Hellman & Friedman Capital Partners VIII (Parallel), L.P. · CIK 0001618902 · 10% owner HFCP VIII (Parallel - A), L.P. · CIK 0001618909 · 10% owner H&F Executives VIII, L.P. · CIK 0001619367 · 10% owner H&F Associates VIII, L.P. · CIK 0001621509 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes Disclosed balance after: 3,630,740 F1 · price: This amount represents the $32.25 secondary public offering price per share of the Common Stock of the Issuer less the underwriting discount of $0.9675 per share. F4 · ownership.nature: Reflects securities directly held by HFCP VII (Parallel-A), L.P. ("HFCP VII Parallel-A"). F11 · ownership.nature: Hellman & Friedman Investors VII, L.P. ("H&F Investors VII") is the general partner of each of the H&F VII Funds. H&F Corporate Investors VII, Ltd. ("H&F VII") is the general partner of H&F Investors VII. Hellman & Friedman Investors VIII, L.P. ("H&F Investors VIII") is the general partner of each of the H&F VIII Funds. H&F Corporate Investors VIII, Ltd. ("H&F VIII") is the general partner of H&F Investors VIII. A three member board of directors of each of H&F VII and H&F VIII has investment discretion over the shares held by the H&F VII Funds and the H&F VIII Funds, respectively. Allen R. Thorpe, a member of the board of directors of PPD, Inc. is a member of the boards of directors of H&F VII and H&F VIII. Read SEC document |
| September 21, 2020 Filed Sep 23, 2020 20:48 UTC | PPD, Inc. PPD · Entity 15247 | SaleCommon Stock | 3,899,092 | $31.28 | $121,973,345.49 |
DisclosureSEC source: 0000899243-20-026096 · doc4.xml · nonDerivative · entry 3 H&F Corporate Investors VIII, Ltd. · CIK 0001767563 · 10% owner Hellman & Friedman Investors VIII, L.P. · CIK 0001801252 · 10% owner Hellman & Friedman Capital Partners VIII, L.P. · CIK 0001618933 · 10% owner Hellman & Friedman Capital Partners VIII (Parallel), L.P. · CIK 0001618902 · 10% owner HFCP VIII (Parallel - A), L.P. · CIK 0001618909 · 10% owner H&F Executives VIII, L.P. · CIK 0001619367 · 10% owner H&F Associates VIII, L.P. · CIK 0001621509 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes Disclosed balance after: 20,244,387 F1 · price: This amount represents the $32.25 secondary public offering price per share of the Common Stock of the Issuer less the underwriting discount of $0.9675 per share. F3 · ownership.nature: Reflects securities directly held by Hellman & Friedman Capital Partners VII (Parallel), L.P. ("HFCP VII Parallel"). F11 · ownership.nature: Hellman & Friedman Investors VII, L.P. ("H&F Investors VII") is the general partner of each of the H&F VII Funds. H&F Corporate Investors VII, Ltd. ("H&F VII") is the general partner of H&F Investors VII. Hellman & Friedman Investors VIII, L.P. ("H&F Investors VIII") is the general partner of each of the H&F VIII Funds. H&F Corporate Investors VIII, Ltd. ("H&F VIII") is the general partner of H&F Investors VIII. A three member board of directors of each of H&F VII and H&F VIII has investment discretion over the shares held by the H&F VII Funds and the H&F VIII Funds, respectively. Allen R. Thorpe, a member of the board of directors of PPD, Inc. is a member of the boards of directors of H&F VII and H&F VIII. Read SEC document |
| September 21, 2020 Filed Sep 23, 2020 20:48 UTC | PPD, Inc. PPD · Entity 15247 | OtherCommon Stock | 883,200 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-20-026096 · doc4.xml · nonDerivative · entry 2 H&F Corporate Investors VIII, Ltd. · CIK 0001767563 · 10% owner Hellman & Friedman Investors VIII, L.P. · CIK 0001801252 · 10% owner Hellman & Friedman Capital Partners VIII, L.P. · CIK 0001618933 · 10% owner Hellman & Friedman Capital Partners VIII (Parallel), L.P. · CIK 0001618902 · 10% owner HFCP VIII (Parallel - A), L.P. · CIK 0001618909 · 10% owner H&F Executives VIII, L.P. · CIK 0001619367 · 10% owner H&F Associates VIII, L.P. · CIK 0001621509 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes Disclosed balance after: 52,884,036 F12 · kind: Represents in-kind distributions of shares of Common Stock previously held by HFCP VII to certain of its direct and indirect partners for the sole purpose of charitable giving. F2 · ownership.nature: Reflects securities directly held by Hellman & Friedman Capital Partners VII, L.P. ("HFCP VII"). F11 · ownership.nature: Hellman & Friedman Investors VII, L.P. ("H&F Investors VII") is the general partner of each of the H&F VII Funds. H&F Corporate Investors VII, Ltd. ("H&F VII") is the general partner of H&F Investors VII. Hellman & Friedman Investors VIII, L.P. ("H&F Investors VIII") is the general partner of each of the H&F VIII Funds. H&F Corporate Investors VIII, Ltd. ("H&F VIII") is the general partner of H&F Investors VIII. A three member board of directors of each of H&F VII and H&F VIII has investment discretion over the shares held by the H&F VII Funds and the H&F VIII Funds, respectively. Allen R. Thorpe, a member of the board of directors of PPD, Inc. is a member of the boards of directors of H&F VII and H&F VIII. Read SEC document |
| September 21, 2020 Filed Sep 23, 2020 20:48 UTC | PPD, Inc. PPD · Entity 15247 | SaleCommon Stock | 9,302,325 | $31.28 | $290,999,981.81 |
DisclosureSEC source: 0000899243-20-026096 · doc4.xml · nonDerivative · entry 1 H&F Corporate Investors VIII, Ltd. · CIK 0001767563 · 10% owner Hellman & Friedman Investors VIII, L.P. · CIK 0001801252 · 10% owner Hellman & Friedman Capital Partners VIII, L.P. · CIK 0001618933 · 10% owner Hellman & Friedman Capital Partners VIII (Parallel), L.P. · CIK 0001618902 · 10% owner HFCP VIII (Parallel - A), L.P. · CIK 0001618909 · 10% owner H&F Executives VIII, L.P. · CIK 0001619367 · 10% owner H&F Associates VIII, L.P. · CIK 0001621509 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes Disclosed balance after: 53,767,236 F1 · price: This amount represents the $32.25 secondary public offering price per share of the Common Stock of the Issuer less the underwriting discount of $0.9675 per share. F2 · ownership.nature: Reflects securities directly held by Hellman & Friedman Capital Partners VII, L.P. ("HFCP VII"). F11 · ownership.nature: Hellman & Friedman Investors VII, L.P. ("H&F Investors VII") is the general partner of each of the H&F VII Funds. H&F Corporate Investors VII, Ltd. ("H&F VII") is the general partner of H&F Investors VII. Hellman & Friedman Investors VIII, L.P. ("H&F Investors VIII") is the general partner of each of the H&F VIII Funds. H&F Corporate Investors VIII, Ltd. ("H&F VIII") is the general partner of H&F Investors VIII. A three member board of directors of each of H&F VII and H&F VIII has investment discretion over the shares held by the H&F VII Funds and the H&F VIII Funds, respectively. Allen R. Thorpe, a member of the board of directors of PPD, Inc. is a member of the boards of directors of H&F VII and H&F VIII. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.